Publications
2024
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
Dawson, J., Green, K., Lazarowicz, H., Cornford, P., & Probert, C. (n.d.). Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review. BJUI Compass. doi:10.1002/bco2.423
Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome.
Conley, T. E., Slater, R., Moss, S., Bulmer, D. C., Negro, J. D. L. R., Ijaz, U. Z., . . . Probert, C. (2024). Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome.. EBioMedicine, 107, 105282. doi:10.1016/j.ebiom.2024.105282
Gas Chromatography-Sensor System Aids Diagnosis of Inflammatory Bowel Disease, and Separates Crohn's from Ulcerative Colitis, in Children.
Slater, R., Tharmaratnam, K., Belnour, S., Auth, M. K. -H., Muhammed, R., Spray, C., . . . Probert, C. (2024). Gas Chromatography-Sensor System Aids Diagnosis of Inflammatory Bowel Disease, and Separates Crohn's from Ulcerative Colitis, in Children.. Sensors (Basel, Switzerland), 24(15), 5079. doi:10.3390/s24155079
Recent advances in measuring the effects of diet on gastrointestinal physiology: Sniffing luminal gases and fecal volatile organic compounds.
Thwaites, P. A., Slater, R., Probert, C., & Gibson, P. R. (2024). Recent advances in measuring the effects of diet on gastrointestinal physiology: Sniffing luminal gases and fecal volatile organic compounds.. JGH open : an open access journal of gastroenterology and hepatology, 8(8), e70006. doi:10.1002/jgh3.70006
Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.
Belnour, S., Slater, R., Tharmaratnam, K., Karl-Heinz Auth, M., Muhammed, R., Spray, C., . . . Allen, S. (2024). Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.. United European gastroenterology journal, 12(6), 780-792. doi:10.1002/ueg2.12603
O64 Microbiome-driven metabotypes influence response to the low FODMAP diet in IBS and implicate short chain fatty acids
Conley, T., Slater, R., Bulmer, D., Moss, S., Negro, J. D. L. R., Ijaz, U., . . . Probert, C. (2024). O64 Microbiome-driven metabotypes influence response to the low FODMAP diet in IBS and implicate short chain fatty acids. In Oral Presentations (pp. A40-A41). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2024-bsg.64
P109 Faecal volatile organic compound detection using a gas chromatography sensor to diagnose inflammatory bowel disease in a paediatric inception cohort
Slater, R., Tharmaratnam, K., Belnour, S., Auth, M., Muhammed, R., Spray, C., . . . Probert, C. (2024). P109 Faecal volatile organic compound detection using a gas chromatography sensor to diagnose inflammatory bowel disease in a paediatric inception cohort. In Poster Presentations (pp. A116.1-A116). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2024-bsg.191
P136 Faecal volatile organic compounds (VOCs) are correlated with bacterial taxa and functional genes in paediatric Crohn’s disease
Slater, R., Frau, A., Belnour, S., Ijaz, U. Z., Allen, S., & Probert, C. (2024). P136 Faecal volatile organic compounds (VOCs) are correlated with bacterial taxa and functional genes in paediatric Crohn’s disease. In Poster Presentations (pp. A134-A135). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2024-bsg.218
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor, N. M., Lee, J. C., Bond, S., Dowling, F., Brezina, B., Patel, K. V., . . . PROFILE Study Group. (2024). A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.. The lancet. Gastroenterology & hepatology, 9(5), 415-427. doi:10.1016/s2468-1253(24)00034-7
Assessing 'response' to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?
Conley, T. E., Parkes, M., Moss, S., & Probert, C. (2024). Assessing 'response' to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?. Clinical nutrition (Edinburgh, Scotland), 43(5), 1079-1086. doi:10.1016/j.clnu.2024.03.017
2023
A novel Monash Pouch diet in patients with an ileoanal pouch is tolerable and has favorable metabolic luminal effects.
Ardalan, Z. S., Yao, C. K., Green, K., Probert, C., Gill, P. A., Rosella, S., . . . Gibson, P. R. (2023). A novel Monash Pouch diet in patients with an ileoanal pouch is tolerable and has favorable metabolic luminal effects.. JGH open : an open access journal of gastroenterology and hepatology, 7(12), 942-952. doi:10.1002/jgh3.13008
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome
Wilson, B., Kanno, T., Slater, R., Rossi, M., Irving, P. M., Lomer, M. C., . . . Whelan, K. (2023). Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 58(4), 404-416. doi:10.1111/apt.17609
The role of iron in the pathogenesis of endometriosis: a systematic review
Wyatt, J., Fernando, S. M., Powell, S. G., Hill, C. J., Arshad, I., Probert, C., . . . Hapangama, D. K. (2023). The role of iron in the pathogenesis of endometriosis: a systematic review. HUMAN REPRODUCTION OPEN, 2023(3). doi:10.1093/hropen/hoad033
A Novel Filter and Embedded Feature Selection Methods applied to High Dimensional Metabolomics Data in Enhancing Colorectal Cancer Classification
Mechanisms affecting the gut of preterm infants in enteral feeding trials: a nested cohort within a randomised controlled trial of lactoferrin
Young, G., Berrington, J. E., Cummings, S., Dorling, J., Ewer, A. K., Frau, A., . . . Embleton, N. (2023). Mechanisms affecting the gut of preterm infants in enteral feeding trials: a nested cohort within a randomised controlled trial of lactoferrin. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 108(3), 272-279. doi:10.1136/archdischild-2022-324477
GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer
Chapman, E. A., Baker, J., Aggarwal, P., Hughes, D. M., Nwosu, A. C., Boyd, M. T., . . . Coyle, S. (2023). GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2). doi:10.3390/ijms24021591
Results of a randomised controlled trial to evaluate Interleukin 1 blockade with anakinra in patients with acute severe ulcerative colitis (IASO)
Raine, T., Vaja, S., Subramanian, S., Brezina, B., Probert, C. S., Steel, A., . . . Kaser, A. (2023). Results of a randomised controlled trial to evaluate Interleukin 1 blockade with anakinra in patients with acute severe ulcerative colitis (IASO). In JOURNAL OF CROHNS & COLITIS Vol. 17 (pp. I43-I46). Retrieved from https://www.webofscience.com/
2022
The impact of almonds and almond processing on gastrointestinal physiology, luminal microbiology, and gastrointestinal symptoms: a randomized controlled trial and mastication study
Creedon, A. C., Dimidi, E., Hung, E. S., Rossi, M., Probert, C., Grassby, T., . . . Whelan, K. (2022). The impact of almonds and almond processing on gastrointestinal physiology, luminal microbiology, and gastrointestinal symptoms: a randomized controlled trial and mastication study. AMERICAN JOURNAL OF CLINICAL NUTRITION, 116(6), 1790-1804. doi:10.1093/ajcn/nqac265
Nfkb2 deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa
Papoutsopoulou, S., Tang, J., Elramli, A. H., Williams, J. M., Gupta, N., Ikuomola, F. I., . . . Pritchard, D. M. (2022). Nfkb2 deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa. American Journal of Physiology: Gastrointestinal and Liver Physiology, 323(4), G306-G317. doi:10.1152/ajpgi.00037.2022
Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study
Coates, E., Wickramasekera, N., Barr, A., Shackley, P., Lee, M., Hind, D., . . . Lobo, A. (2022). Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. HEALTH TECHNOLOGY ASSESSMENT, 26(41). doi:10.3310/RHXR5192
Origin and Emission of Volatile Biomarkers from Feces
Slater, R., Farrow, O., George, M., & Probert, C. S. (2022). Origin and Emission of Volatile Biomarkers from Feces. In Volatile Biomarkers for Human Health (pp. 61-86). The Royal Society of Chemistry. doi:10.1039/9781839166990-00061
Origin and emission of volatile biomarkers from feces
Slater, R., Farrow, O., George, M., & Probert, C. S. (2022). Origin and emission of volatile biomarkers from feces. In Volatile Biomarkers for Human Health: From Nature to Artificial Senses (pp. 61-86).
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study
Smith, P. J., Critchley, L., Storey, D., Gregg, B., Stenson, J., Kneebone, A., . . . Subramanian, S. (2022). Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. JOURNAL OF CROHNS & COLITIS, 16(9), 1436-1446. doi:10.1093/ecco-jcc/jjac053
Patient preferences for treatment in steroid resistant ulcerative colitis - a discrete-choice experiment
Wickramasekera, N., Coates, E., Barr, A., Lee, M. J., Blackwell, S., Bedford, H., . . . Lobo, A. J. (2022). Patient preferences for treatment in steroid resistant ulcerative colitis - a discrete-choice experiment. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 57(7), 797-806. doi:10.1080/00365521.2022.2036808
Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer
Lett, L., George, M., Slater, R., Costello, B. D. L., Ratcliffe, N., Garcia-Finana, M., . . . Probert, C. (2022). Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer. British Journal of Cancer. doi:10.1038/s41416-022-01785-8
The faecal metabolome and mycobiome in Parkinson's disease
De Pablo-Fernandez, E., Gebeyehu, G. G., Flain, L., Slater, R., Frau, A., Ijaz, U. Z., . . . Probert, C. (2022). The faecal metabolome and mycobiome in Parkinson's disease. Parkinsonism & Related Disorders, 95, 65-69. doi:10.1016/j.parkreldis.2022.01.005
2021
Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, but Ferrous Sulphate Does
Mahalhal, A., Frau, A., Burkitt, M. D., Ijaz, U. Z., Lamb, C. A., Mansfield, J. C., . . . Probert, C. S. (2021). Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, but Ferrous Sulphate Does. NUTRIENTS, 13(7). doi:10.3390/nu13072269
The Stool Volatile Metabolome of Pre-Term Babies
Frau, A., Lett, L., Slater, R., Young, G. R., Stewart, C. J., Berrington, J., . . . Probert, C. (2021). The Stool Volatile Metabolome of Pre-Term Babies. MOLECULES, 26(11). doi:10.3390/molecules26113341
The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation
Nelson, A., Stewart, C. J., Kennedy, N. A., Lodge, J. K., Tremelling, M., Probert, C. S., . . . Lamb, C. A. (2021). The Impact of <i>NOD2</i> Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation. JOURNAL OF CROHNS & COLITIS, 15(5), 800-812. doi:10.1093/ecco-jcc/jjaa220
O1 Faecal volatile organic compounds in paediatric inflammatory bowel disease
Belnour, S., Slater, R., Auth, M. K. H., Muhammed, R., Spray, C., Wang, D., . . . Allen, S. (2021). O1 Faecal volatile organic compounds in paediatric inflammatory bowel disease. In Plenary (pp. A1.1-A1). BMJ Publishing Group Ltd. doi:10.1136/flgastro-2021-bspghan.1
Long-Term Iron Deficiency and Dietary Iron Excess Exacerbate Acute Dextran Sodium Sulphate-Induced Colitis and Are Associated with Significant Dysbiosis
Mahalhal, A., Burkitt, M. D., Duckworth, C. A., Hold, G. L., Campbell, B. J., Pritchard, D. M., & Probert, C. S. (2021). Long-Term Iron Deficiency and Dietary Iron Excess Exacerbate Acute Dextran Sodium Sulphate-Induced Colitis and Are Associated with Significant Dysbiosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(7). doi:10.3390/ijms22073646
A Comparison of the Colonic Microbiome and Volatile Organic Compound Metabolome of <i>Anoplocephala perfoliata</i> Infected and Non-Infected Horses: A Pilot Study
Slater, R., Frau, A., Hodgkinson, J., Archer, D., & Probert, C. (2021). A Comparison of the Colonic Microbiome and Volatile Organic Compound Metabolome of <i>Anoplocephala perfoliata</i> Infected and Non-Infected Horses: A Pilot Study. ANIMALS, 11(3). doi:10.3390/ani11030755
Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition
Qualter, P., Rouncefield-Swales, A., Bray, L., Blake, L., Allen, S., Probert, C., . . . Carter, B. (2021). Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition. QUALITY OF LIFE RESEARCH, 30(2), 497-506. doi:10.1007/s11136-020-02653-9
Enhanced neoplasia detection in chronic ulcerative colitis: the ENDCaP-C diagnostic accuracy study
Awasthi, A., Barbour, J., Beggs, A., Bhandari, P., Blakeway, D., Brookes, M., . . . Wallis, Y. (2021). Enhanced neoplasia detection in chronic ulcerative colitis: the ENDCaP-C diagnostic accuracy study.
Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach.
Frau, A., Ijaz, U. Z., Slater, R., Jonkers, D., Penders, J., Campbell, B. J., . . . Probert, C. S. J. (2021). Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach. GUT MICROBES, 13(1). doi:10.1080/19490976.2021.1930871
Lactoferrin impact on gut microbiota in preterm infants with late-onset sepsis or necrotising enterocolitis: the MAGPIE mechanisms of action study
Embleton, N., Berrington, J., Cummings, S., Dorling, J., Ewer, A., Frau, A., . . . Young, G. R. (2021). Lactoferrin impact on gut microbiota in preterm infants with late-onset sepsis or necrotising enterocolitis: the MAGPIE mechanisms of action study.
THE IMPACT OF NOD2 DEFICIENCY ON THE GUT MYCOBIOTA IN CROHN'S DISEASE PATIENTS IN REMISSION
Bridge, S., Nelson, A., Kennedy, N., Lodge, J., Morgan, H., Berry, S., . . . Lamb, C. (2021). THE IMPACT OF NOD2 DEFICIENCY ON THE GUT MYCOBIOTA IN CROHN'S DISEASE PATIENTS IN REMISSION. In GUT Vol. 70 (pp. A86). doi:10.1136/gutjnl-2020-bsgcampus.163
2020
Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological Agents
Conley, T. E., Probert, C., & Subramanian, S. (2020). Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological Agents. JOURNAL OF CROHNS & COLITIS, 14(12), 1794-1795. doi:10.1093/ecco-jcc/jjaa187
Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
Lloyd, K., Papoutsopoulou, S., Smith, E., Stegmaier, P., Bergey, F., Morris, L., . . . Burkitt, M. D. (2020). Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. DISEASE MODELS & MECHANISMS, 13(11). doi:10.1242/dmm.044040
Optimisation of Urine Sample Preparation for Headspace-Solid Phase Microextraction Gas Chromatography-Mass Spectrometry: Altering Sample pH, Sulphuric Acid Concentration and Phase Ratio
Aggarwal, P., Baker, J., Boyd, M. T., Coyle, S., Probert, C., & Chapman, E. A. (2020). Optimisation of Urine Sample Preparation for Headspace-Solid Phase Microextraction Gas Chromatography-Mass Spectrometry: Altering Sample pH, Sulphuric Acid Concentration and Phase Ratio. METABOLITES, 10(12). doi:10.3390/metabo10120482
Using Volatile Organic Compounds to Investigate the Effect of Oral Iron Supplementation on the Human Intestinal Metabolome
Ahmed, A., Slater, R., Lewis, S., & Probert, C. (2020). Using Volatile Organic Compounds to Investigate the Effect of Oral Iron Supplementation on the Human Intestinal Metabolome. MOLECULES, 25(21). doi:10.3390/molecules25215113
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
Din, S., Kent, A., Pollok, R. C., Meade, S., Kennedy, N. A., Arnott, I., . . . Irving, P. M. (2020). Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. GUT, 69(10), 1769-1777. doi:10.1136/gutjnl-2020-321927
Sustaining, Forming, and Letting Go of Friendships for Young People with Inflammatory Bowel Disease (IBD): A Qualitative Interview-Based Study.
Rouncefield-Swales, A., Carter, B., Bray, L., Blake, L., Allen, S., Probert, C., . . . Qualter, P. (2020). Sustaining, Forming, and Letting Go of Friendships for Young People with Inflammatory Bowel Disease (IBD): A Qualitative Interview-Based Study.. International journal of chronic diseases, 2020, 7254972. doi:10.1155/2020/7254972
Faecal volatile organic compounds in preterm babies at risk of necrotising enterocolitis: the DOVE study
Probert, C., Greenwood, R., Mayor, A., Hughes, D., Aggio, R., Jackson, R. E., . . . Ewer, A. K. (2020). Faecal volatile organic compounds in preterm babies at risk of necrotising enterocolitis: the DOVE study. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 105(5), 474-479. doi:10.1136/archdischild-2019-318221
Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease
Rhodes, J. M., Subramanian, S., Flanagan, P. K., Horgan, G. W., Martin, K., Mansfield, J., . . . Probert, C. (2020). Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease. Digestive Diseases and Sciences. doi:10.1007/s10620-020-06477-y
"I Don't Like to Make a Big Thing out of It": A Qualitative Interview-Based Study Exploring Factors Affecting Whether Young People Tell or Do Not Tell Their Friends about Their IBD.
Carter, B., Rouncefield-Swales, A., Bray, L., Blake, L., Allen, S., Probert, C., . . . Qualter, P. (2020). "I Don't Like to Make a Big Thing out of It": A Qualitative Interview-Based Study Exploring Factors Affecting Whether Young People Tell or Do Not Tell Their Friends about Their IBD.. The International Journal of Chronic Disease, 2020, 1059025. doi:10.1155/2020/1059025
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Kennedy, N. A., Jones, G. -R., Lamb, C. A., Appleby, R., Arnott, I., Beattie, R. M., . . . Lees, C. W. (2020). British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. GUT, 69(6), 984-990. doi:10.1136/gutjnl-2020-321244
Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanisms
Papoutsopoulou, S., Satsangi, J., Campbell, B. J., & Probert, C. S. (2020). Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanisms. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 51(12), 1268-1285. doi:10.1111/apt.15774
2019
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients
Papoutsopoulou, S., Burkitt, M. D., Bergey, F., England, H., Hough, R., Schmidt, L., . . . Probert, C. S. (2019). Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients. FRONTIERS IN IMMUNOLOGY, 10. doi:10.3389/fimmu.2019.02168
SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells
Dai, L., Liu, Y., Cheng, L., Wang, H., Lin, Y., Shi, G., . . . Deng, H. (2019). SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells. MUCOSAL IMMUNOLOGY, 12(5), 1130-1140. doi:10.1038/s41385-019-0178-9
DNA extraction and amplicon production strategies deeply influence the outcome of gut mycobiome studies
Frau, A., Kenny, J. G., Lenzi, L., Campbell, B. J., Ijaz, U. Z., Duckworth, C. A., . . . Probert, C. S. J. (2019). DNA extraction and amplicon production strategies deeply influence the outcome of gut mycobiome studies. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-44974-x
CD4 T-CELL HLA-U PSEUDOGENE AT BASELINE PREDICTS CLINICAL REMISSION TO ANTI-TNF AGENTS IN ULCERATIVE COLITIS
Subramanian, S., Rainbow, L., Gemmell, M., Fang, Y., Haldenby, S., Hough, R., & Probert, C. (2019). CD4 T-CELL HLA-U PSEUDOGENE AT BASELINE PREDICTS CLINICAL REMISSION TO ANTI-TNF AGENTS IN ULCERATIVE COLITIS. In GUT Vol. 68 (pp. A64-A65). doi:10.1136/gutjnl-2019-BSGAbstracts.127
Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
Bomhof, M. R., Parnell, J. A., Ramay, H. R., Crotty, P., Rioux, K. P., Probert, C. S., . . . Reimer, R. A. (2019). Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. EUROPEAN JOURNAL OF NUTRITION, 58(4), 1735-1745. doi:10.1007/s00394-018-1721-2
METABOLOMICS & MULTI-OMICS ANALYSIS OF CROHN'S DISEASE
Frau, A., Hough, R., Ijaz, U., Campbell, B., Kenny, J., Hall, N., . . . Probert, C. (2019). METABOLOMICS & MULTI-OMICS ANALYSIS OF CROHN'S DISEASE. In GUT Vol. 68 (pp. A68). doi:10.1136/gutjnl-2019-BSGAbstracts.131
A longitudinal study of the faecal microbiome and metabolome of periparturient mares
Salem, S. E., Hough, R., Probert, C., Maddox, T. W., Antczak, P., Ketley, J. M., . . . Archer, D. C. (2019). A longitudinal study of the faecal microbiome and metabolome of periparturient mares. PeerJ, 7. doi:10.7717/peerj.6687
Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis.
Davis, R., McParland, P., Dodd, S., Storey, D., Probert, C., Collins, P., . . . Subramanian, S. (2019). Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis.. European journal of gastroenterology & hepatology. doi:10.1097/meg.0000000000001395
Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice.
Reade, S., Williams, J. M., Aggio, R., Duckworth, C. A., Mahalhal, A., Hough, R., . . . Probert, C. S. (2019). Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice. FASEB JOURNAL, 33(3), 3129-3136. doi:10.1096/fj.201800076RR
Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial.
Thomas, M. G., Bayliss, C., Bond, S., Dowling, F., Galea, J., Jairath, V., . . . Raine, T. (2019). Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial.. BMJ open, 9(2), e023765. doi:10.1136/bmjopen-2018-023765
Macrophage-specific NF-κB activation dynamics can segregate inflammatory bowel disease patients
Papoutsopoulou, S., Burkitt, M., Bergey, F., England, H., Hough, R., Schmidt, L., . . . Probert, C. (2019). Macrophage-specific NF-κB activation dynamics can segregate inflammatory bowel disease patients. doi:10.1101/535096
CD4 T-cell transcriptome analysis at baseline predicts clinical remission to anti-TNF agents in ulcerative colitis (UC)
Subramanian, S., Rainbow, L., Gemmell, M., Hough, R., Haldenby, S., Gureviciute, A., . . . Probert, C. (2019). CD4 T-cell transcriptome analysis at baseline predicts clinical remission to anti-TNF agents in ulcerative colitis (UC). In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S132-S133). doi:10.1093/ecco-jcc/jjy222.217
Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis
Subramanian, S., Davis, R., MacParland, P., Dodd, S., Storey, D., Probert, C., . . . Dibb, M. (2019). Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis. In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S321). doi:10.1093/ecco-jcc/jjy222.547
Multi-omics analysis suggests an active role of fungi in Crohn's disease
Frau, A., Ijaz, U. Z., Hough, R., Campbell, B. J., Kenny, J. G., Hall, N., . . . Probert, C. S. J. (2019). Multi-omics analysis suggests an active role of fungi in Crohn's disease. In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S545). doi:10.1093/ecco-jcc/jjy222.966
Using systems medicine to identify a therapeutic agent with potential for repurposing in Inflammatory Bowel Disease
Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply
Bond, A., & Probert, C. (2019). Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 49(8), 1087-1088. doi:10.1111/apt.15196
Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer
Bond, A., Greenwood, R., Lewis, S., Corfe, B., Sarkar, S., O'Toole, P., . . . Probert, C. (2019). Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer. Alimentary Pharmacology and Therapeutics, 49(8), 1005-1012. doi:10.1111/apt.15140
2018
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
Lenti, M. V., Levison, S., Eliadou, E., Willert, R., Kemp, K., Carter, A., . . . Selinger, C. P. (2018). A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study. DIGESTIVE AND LIVER DISEASE, 50(12), 1299-1304. doi:10.1016/j.dld.2018.07.007
Oral iron exacerbates colitis and influences the intestinal microbiome
Mahalhal, A., Williams, J. M., Johnson, S., Ellaby, N., Duckworth, C. A., Burkitt, M. D., . . . Probert, C. S. (2018). Oral iron exacerbates colitis and influences the intestinal microbiome. PLOS ONE, 13(10). doi:10.1371/journal.pone.0202460
Oral iron exacerbates colitis and influences the intestinal microbiome
Mahalhal, A., Williams, J., Johnson, S., Ellaby, N., Duckworth, C., Burkitt, M., . . . Probert, C. (2018). Oral iron exacerbates colitis and influences the intestinal microbiome. doi:10.1101/385997
Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis).
Probert, C. S. J., Sebastian, S., Gaya, D. R., Hamlin, P. J., Gillespie, G., Rose, A., . . . Cummings, F. (2018). Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis). BMJ OPEN GASTROENTEROLOGY, 5(1). doi:10.1136/bmjgast-2018-000212
A SPECIALISED IBD SERVICE PROVIDES EQUALITY OF ACCESS TO HEALTHCARE, IRRESPECTIVE OF DEPRIVATION INDICES
Burkitt, M., Storey, D., Gregg, B., Probert, C., & Sawbridge, D. (2018). A SPECIALISED IBD SERVICE PROVIDES EQUALITY OF ACCESS TO HEALTHCARE, IRRESPECTIVE OF DEPRIVATION INDICES. In GUT Vol. 67 (pp. A233). doi:10.1136/gutjnl-2018-BSGAbstracts.465
BACTERIAL AND FUNGAL COMMUNITIES IN FAECES AND BIOPSIES IN IBD
Frau, A., Ijaz, U. Z., Campbell, B., Darby, A., Kenny, J., Hall, N., & Probert, C. (2018). BACTERIAL AND FUNGAL COMMUNITIES IN FAECES AND BIOPSIES IN IBD. In GUT Vol. 67 (pp. A58-A59). doi:10.1136/gutjnl-2018-BSGAbstracts.115
BASELINE CALPROTECTIN PREDICTS STEROID FREE REMISSION WITH BIOLOGICAL THERAPY IN ULCERATIVE COLITIS AT 1 YEAR
Subramanian, S., Davies, R., Dodd, S., Storey, D., Steel, A., Dibb, M., . . . Mcparland, P. (2018). BASELINE CALPROTECTIN PREDICTS STEROID FREE REMISSION WITH BIOLOGICAL THERAPY IN ULCERATIVE COLITIS AT 1 YEAR. In GUT Vol. 67 (pp. A97-A98). doi:10.1136/gutjnl-2018-BSGAbstracts.192
IDENTIFICATION OF A NOVEL THERAPEUTIC AGENT FOR TREATING IBD GUIDED BY SYSTEMS MEDICINE
Burkitt, M., Lloyd, K., Papoutsopoulou, S., Smith, E., Stegmaier, P., Pritchard, D. M., . . . Probert, C. (2018). IDENTIFICATION OF A NOVEL THERAPEUTIC AGENT FOR TREATING IBD GUIDED BY SYSTEMS MEDICINE. In GUT Vol. 67 (pp. A52). doi:10.1136/gutjnl-2018-BSGAbstracts.104
INTESTINAL DYSBIOSIS OCCURS IN IRON DEFICIENCY AS WELL AS ACTIVE IBD
Mahalhal, A., Subramanian, S., Pritchard, D. M., & Probert, C. S. (2018). INTESTINAL DYSBIOSIS OCCURS IN IRON DEFICIENCY AS WELL AS ACTIVE IBD. In GUT Vol. 67 (pp. A193). doi:10.1136/gutjnl-2018-BSGAbstracts.384
Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician
Miehlke, S., Barreiro-de Acosta, M., Bouma, G., Carpio, D., Magro, F., Moreels, T., & Probert, C. (2018). Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33(9), 1574-1581. doi:10.1111/jgh.14151
Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome
Rossi, M., Aggio, R., Staudacher, H. M., Lomer, M. C., Lindsay, J. O., Irving, P., . . . Whelan, K. (2018). Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 16(3), 385-391.e1. doi:10.1016/j.cgh.2017.09.055
The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease
Kennedy, N. A., Lamb, C. A., Berry, S. H., Walker, A. W., Mansfield, J., Parkes, M., . . . Consortium, U. K. I. B. D. G. (2018). The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease. INFLAMMATORY BOWEL DISEASES, 24(3), 583-592. doi:10.1093/ibd/izx061
A comparison of sample preparation methods for extracting volatile organic compounds (VOCs) from equine faeces using HS-SPME
Hough, R., Archer, D., & Probert, C. (2018). A comparison of sample preparation methods for extracting volatile organic compounds (VOCs) from equine faeces using HS-SPME. METABOLOMICS, 14(02), 10 pages. doi:10.1007/s11306-017-1315-7
Crohn's disease is characterised by a fungal dysbiosis
Frau, A., Jonkers, D., Penders, J., Pierik, M., Ijaz, U. Z., Campbell, B., . . . Probert, C. (2018). Crohn's disease is characterised by a fungal dysbiosis. In JOURNAL OF CROHNS & COLITIS Vol. 12 (pp. S550-S551). Retrieved from https://www.webofscience.com/
2017
P-113 Biomarkers of dying in cancer patients; an exploration of the biology of dying
Coyle, S., Reid, V. L., McDonald, R., Nwosu, A. C., Mason, S. R., Probert, C., & Ellershaw, J. E. (2017). P-113 Biomarkers of dying in cancer patients; an exploration of the biology of dying. In Patient care (pp. A49.3-A50). British Medical Journal Publishing Group. doi:10.1136/bmjspcare-2017-hospice.138
Effectiveness and Safety of Vedolizumab (VDZ) in IBD Patients: A Multicenter Experience of "Real World Data" From the UK
Lenti, M. V., Levison, S., Eliadou, E., Willert, R., Kemp, K., Stansfield, C., . . . Selinger, C. (2017). Effectiveness and Safety of Vedolizumab (VDZ) in IBD Patients: A Multicenter Experience of "Real World Data" From the UK. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S381). doi:10.14309/00000434-201710001-00688
EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB (VDZ) IN IBD PATIENTS: A MULTICENTRE EXPERIENCE OF 'REAL WORLD DATA' FROM THE UK
Lenti, M. V., Levison, S., Eliadou, E., Willert, R. R., Kemp, K., Stansfield, C., . . . Selinger, C. P. (2017). EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB (VDZ) IN IBD PATIENTS: A MULTICENTRE EXPERIENCE OF 'REAL WORLD DATA' FROM THE UK. In GUT Vol. 66 (pp. A157-A158). doi:10.1136/gutjnl-2017-314472.308
GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS: PATIENT-REPORTED OUTCOMES OF PARTIAL MAYO SCORE RESULTS FROM THE GO-COLITIS STUDY
Sebastian, S., Probert, C., Gaya, D., Hamlin, P. J., Irving, P., Gillespie, G., . . . Wheeler, C. (2017). GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS: PATIENT-REPORTED OUTCOMES OF PARTIAL MAYO SCORE RESULTS FROM THE GO-COLITIS STUDY. In GUT Vol. 66 (pp. A122-A123). doi:10.1136/gutjnl-2017-314472.240
INFLUENCE OF IRON ON GUT MICROBIAL COMPOSITION IN ACUTE DSS-INDUCED COLITIS IN C57BL/6 MICE
Mahalhal, A., Campbell, B., Pritchard, D. M., & Probert, C. (2017). INFLUENCE OF IRON ON GUT MICROBIAL COMPOSITION IN ACUTE DSS-INDUCED COLITIS IN C57BL/6 MICE. In GUT Vol. 66 (pp. A234). doi:10.1136/gutjnl-2017-314472.456
LONGITUDINAL INVESTIGATION OF MICROBIOTA DYNAMICS IN A MODEL OF MILD CHRONIC DSSINDUCED COLITIS IN WILD-TYPE (WT) C57BL/6 MICE RECEIVING DIETS WITH DIFFERENT IRON CONTENTS
Mahalhal, A., Campbell, B., Pritchard, D. M., & Probert, C. (2017). LONGITUDINAL INVESTIGATION OF MICROBIOTA DYNAMICS IN A MODEL OF MILD CHRONIC DSSINDUCED COLITIS IN WILD-TYPE (WT) C57BL/6 MICE RECEIVING DIETS WITH DIFFERENT IRON CONTENTS. In GUT Vol. 66 (pp. A237). doi:10.1136/gutjnl-2017-314472.463
VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL
Rossi, M., Aggio, R., Staudacher, H., Lomer, M., Lindsay, J., Irving, P., . . . Whelan, K. (2017). VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL. In GUT Vol. 66 (pp. A12-A13). doi:10.1136/gutjnl-2017-314472.24
Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials
Embleton, N. D., Berrington, J. E., Dorling, J., Ewer, A. K., Juszczak, E., Kirby, J. A., . . . Cummings, S. P. (2017). Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials. FRONTIERS IN NUTRITION, 4. doi:10.3389/fnut.2017.00014
A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying
Reid, V. L., McDonald, R., Nwosu, A. C., Mason, S. R., Probert, C., Ellershaw, J. E., & Coyle, S. (2017). A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying. PLOS ONE, 12(4). doi:10.1371/journal.pone.0175123
A systematically structured review on biomarkers of dying in cancer patients at the end of life; an exploration of potential mechanisms for the biology of dying
Reid, V., McDonald, R., Nwosu, A. C., Mason, S., Probert, C., Ellershaw, J., & Coyle, S. (2017). A systematically structured review on biomarkers of dying in cancer patients at the end of life; an exploration of potential mechanisms for the biology of dying. In BMJ Supportive and Palliative Care Vol. Volume 7. Belfast Waterfront: BMJ Publishing Group.
EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS
Probert, C., Gaya, D., Hamlin, P. J., Irving, P., Sebastian, S., Gillespie, G., . . . Wheeler, C. (2017). EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS. In GUT Vol. 66 (pp. A8). doi:10.1136/gutjnl-2017-314127.20
PATIENT-REPORTED QUALITY OF LIFE DURING GOLIMUMABINDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS STUDY
Irving, P., Sebastian, S., Probert, C., Gaya, D., Hamlin, P. J., Gillespie, G., . . . Wheeler, C. (2017). PATIENT-REPORTED QUALITY OF LIFE DURING GOLIMUMABINDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS STUDY. In GUT Vol. 66 (pp. A8). doi:10.1136/gutjnl-2017-314127.21
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
Carr, D. F., Ayehunie, S., Davies, A., Duckworth, C. A., French, S., Hall, N., . . . Pirmohamed, M. (2017). Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury. PHARMACOLOGY & THERAPEUTICS, 172, 181-194. doi:10.1016/j.pharmthera.2017.01.002
VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL
Rossi, M., Aggio, R., Staudacher, H., Lomer, M., Lindsay, J. O., Irving, P. M., . . . Whelan, K. (2017). VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL. In GASTROENTEROLOGY Vol. 152 (pp. S713-S714). doi:10.1016/S0016-5085(17)32486-1
The use of randomisation-based efficacy estimators in non-inferiority trials
Gillespie, D., Farewell, D., Barrett-Lee, P., Casbard, A., Hawthorne, A. B., Hurt, C., . . . Hood, K. (2017). The use of randomisation-based efficacy estimators in non-inferiority trials. TRIALS, 18. doi:10.1186/s13063-017-1837-3
Dual-focus Magnification, High-Definition Endoscopy Improves Pathology Detection in Direct-to-Test Diagnostic Upper Gastrointestinal Endoscopy
Bond, A., Burkitt, M. D., Cox, T., Smart, H. L., Probert, C., Haslam, N., & Sarkar, S. (2017). Dual-focus Magnification, High-Definition Endoscopy Improves Pathology Detection in Direct-to-Test Diagnostic Upper Gastrointestinal Endoscopy. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 26(1), 19-24. doi:10.15403/jgld.2014.1121.261.gen
New-Generation High-Definition Colonoscopes Increase Adenoma Detection when Screening a Moderate-Risk Population for Colorectal Cancer
Bond, A., O'Toole, P., Fisher, G., Subramanian, S., Haslam, N., Probert, C., . . . Sarkar, S. (2017). New-Generation High-Definition Colonoscopes Increase Adenoma Detection when Screening a Moderate-Risk Population for Colorectal Cancer. CLINICAL COLORECTAL CANCER, 16(1), 44-50. doi:10.1016/j.clcc.2016.07.006
O-5 A systematically structured review on biomarkers of dying in cancer patients at the end of life; an exploration of potential mechanisms for the biology of dying
Reid, V., McDonald, R., Nwosu, A. C., Mason, S. R., Probert, C., Ellershaw, J. E., & Coyle, S. (2017). O-5 A systematically structured review on biomarkers of dying in cancer patients at the end of life; an exploration of potential mechanisms for the biology of dying. Oral Presentations, A2.2-A2. doi:10.1136/bmjspcare-2017-00133.5
Gastrointestinal malignancies at five regional referral hospitals in Uganda
Obayo, S., Lukwago, L., Orem, J., Faulx, A. L., & Probert, C. S. (2017). Gastrointestinal malignancies at five regional referral hospitals in Uganda. AFRICAN HEALTH SCIENCES, 17(4), 1051-1058. doi:10.4314/ahs.v17i4.13
Volatile organic compounds predict response to both low FODMAP diet and probiotics in irritable bowel syndrome: a randomised controlled trial
Rossi, M., Aggio, R., Staudacher, H., Lomer, M., Lindsay, J. O., Irving, P., . . . Whelan, K. (2017). Volatile organic compounds predict response to both low FODMAP diet and probiotics in irritable bowel syndrome: a randomised controlled trial. In PROCEEDINGS OF THE NUTRITION SOCIETY Vol. 76 (pp. E156). doi:10.1017/S0029665117003184
2016
Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis
Aggio, R. G. M., White, P., Jayasena, H., Lacy Costello, B., Ratcliffe, N. M., & Probert, C. S. J. (2016). Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis. Alimentary Pharmacology and Therapeutics, 45(1), 82-90. doi:10.1111/apt.13822
Collecting biological material from palliative care patients in the last weeks of life: a feasibility study
Coyle, S., Scott, A., Nwosu, A. C., Latten, R., Wilson, J., Mayland, C. R., . . . Ellershaw, J. (2016). Collecting biological material from palliative care patients in the last weeks of life: a feasibility study. BMJ OPEN, 6(11). doi:10.1136/bmjopen-2016-011763
Giardiasis.
Minetti, C., Chalmers, R. M., Beeching, N. J., Probert, C., & Lamden, K. (2016). CLINICAL UPDATES Giardiasis. BMJ-BRITISH MEDICAL JOURNAL, 355. doi:10.1136/bmj.i5369
Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease
Reid, D. T., McDonald, B., Khalid, T., Vo, T., Schenck, L. P., Surette, M. G., . . . Eksteen, B. (2016). Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1862(7), 1337-1344. doi:10.1016/j.bbadis.2016.04.005
INFLUENCE OF IRON SUPPLEMENTATION ON THE NATURAL HISTORY OF COLITIS
Mahalhal, A., Campbell, B. J., Pritchard, D. M., & Probert, C. S. (2016). INFLUENCE OF IRON SUPPLEMENTATION ON THE NATURAL HISTORY OF COLITIS. In GUT Vol. 65 (pp. A244). doi:10.1136/gutjnl-2016-312388.457
Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis
Merga, Y. J., O Hara, A., Burkitt, M. D., Duckworth, C. A., Probert, C. S., Campbell, B. J., & Pritchard, D. M. (2016). Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis. American Journal of Physiology - Gastrointestinal and Liver Physiology, 310(11), G1081-G1090. doi:10.1152/ajpgi.00026.2016
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply
Ahmed, I., Greenwood, R., Costello, B., Ratcliffe, N., & Probert, C. (2016). Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply. In ALIMENTARY PHARMACOLOGY & THERAPEUTICS (Vol. 43, Iss. 11, pp. 1241-1242). doi:10.1111/apt.13617
Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use
Subramanian, S., Asher, R., Weston, W., Rimmer, M., McConville, A., Malin, A., . . . Rhodes, J. M. (2016). Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use. INFLAMMATORY BOWEL DISEASES, 22(8), 1902-1907. doi:10.1097/MIB.0000000000000803
Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort
Bond, A. D., Burkitt, M. D., Sawbridge, D., Corfe, B. M., & Probert, C. S. (2016). Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 25(1), 71-77. Retrieved from https://www.webofscience.com/
Freeze-drying: an alternative method for the analysis of volatile organic compounds in the headspace of urine samples using solid phase micro-extraction coupled to gas chromatography - mass spectrometry
Aggio, R. B. M., Mayor, A., Coyle, S., Reade, S., Khalid, T., Ratcliffe, N. M., & Probert, C. S. J. (2016). Freeze-drying: an alternative method for the analysis of volatile organic compounds in the headspace of urine samples using solid phase micro-extraction coupled to gas chromatography - mass spectrometry. CHEMISTRY CENTRAL JOURNAL, 10. doi:10.1186/s13065-016-0155-2
Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease
Ahmed, I., Greenwood, R., Costello, B., Ratcliffe, N., & Probert, C. S. (2016). Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 43(5), 596-611. doi:10.1111/apt.13522
The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies
Aggio, R. B. M., Costello, B. D. L., White, P., Khalid, T., Ratcliffe, N. M., Persad, R., & Probert, C. S. J. (2016). The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies. Journal of Breath Research, 10(1). doi:10.1088/1752-7155/10/1/017106
Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
Probert, C., Gaya, D. R., Hamlin, P. J., Irving, P., Sebastian, S., Gillespie, G., . . . Wheeler, C. (2016). Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study. JOURNAL OF CROHNS & COLITIS, 10, S57-S58. Retrieved from https://www.webofscience.com/
Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
Irving, P., Probert, C., Gaya, D. R., Hamlin, P. J., Sebastian, S., Gillespie, G., . . . Wheeler, C. (2016). Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study. In JOURNAL OF CROHNS & COLITIS Vol. 10 (pp. S250-S251). Retrieved from https://www.webofscience.com/
2015
The role of budesonide in the management of Crohn's disease
Boal, A., & Probert, C. (2015). The role of budesonide in the management of Crohn's disease. Gastrointestinal Nursing, 13(10), 26-33. doi:10.12968/gasn.2015.13.10.26
The use of randomisation-based efficacy estimators in non-inferiority trials
Gillespie, D., Hood, K., Farewell, D., Hawthorne, A., Probert, C., Stenson, R., . . . Murray, N. (2015). The use of randomisation-based efficacy estimators in non-inferiority trials. In TRIALS Vol. 16. doi:10.1186/1745-6215-16-S2-P129
Urinary Volatile Organic Compounds for the Detection of Prostate Cancer
Khalid, T., Aggio, R., White, P., Costello, B. D. L., Persad, R., Al-Kateb, H., . . . Ratcliffe, N. (2015). Urinary Volatile Organic Compounds for the Detection of Prostate Cancer. PLOS ONE, 10(11). doi:10.1371/journal.pone.0143283
Biosimilars: what's around the corner?
Russell, R. K., Irving, P., & Probert, C. (2015). Biosimilars: what's around the corner?. FRONTLINE GASTROENTEROLOGY, 6(4), 262-263. doi:10.1136/flgastro-2015-100587
Managing acute severe ulcerative colitis in the hosptialised setting
McClements, D. I., & Probert, C. (2015). Managing acute severe ulcerative colitis in the hosptialised setting. FRONTLINE GASTROENTEROLOGY, 6(4), 241-245. doi:10.1136/flgastro-2014-100459
Investigation of Volatile Organic Compounds Emitted from Faeces for the Diagnosis of Giardiasis
Bond, A., Vernon, A., Reade, S., Mayor, A., Minetti, C., Wastling, J., . . . Probert, C. (2015). Investigation of Volatile Organic Compounds Emitted from Faeces for the Diagnosis of Giardiasis. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 24(3), 281-286. Retrieved from https://www.webofscience.com/
Upper gastrointestinal diseases in patients for endoscopy in South-Western Uganda
Obayo, S., Muzoora, C., Ocama, P., Cooney, M. M., Wilson, T., & Probert, C. S. (2015). Upper gastrointestinal diseases in patients for endoscopy in South-Western Uganda. AFRICAN HEALTH SCIENCES, 15(3), 959-966. doi:10.4314/ahs.v15i3.33
Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease
Poon, S. S., Asher, R., Jackson, R., Kneebone, A., Collins, P., Probert, C., . . . Subramanian, S. (2015). Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease. JOURNAL OF CROHNS & COLITIS, 9(8), 640-646. doi:10.1093/ecco-jcc/jjv084
CONTRACEPTIVE PILL AND B12: LOW YIELD FROM INVESTIGATING LOW SERUM B12 IN WOMEN TAKING THE OCP
Clark, K., Chinnappan, L., Reilly, I., & Probert, C. (2015). CONTRACEPTIVE PILL AND B12: LOW YIELD FROM INVESTIGATING LOW SERUM B12 IN WOMEN TAKING THE OCP. In GUT Vol. 64 (pp. A520). doi:10.1136/gutjnl-2015-309861.1137
CORRELATION OF A PATIENT REPORTED SINGLE ITEM GLOBAL DISEASE RATING SCALE TO CLINICAL AND BIOLOGICAL MARKERS OF DISEASE ACTIVITY
Rimmer, M., Asher, R., Jackson, R., Race, G., Collins, P., Dibb, M., . . . Subramanian, S. (2015). CORRELATION OF A PATIENT REPORTED SINGLE ITEM GLOBAL DISEASE RATING SCALE TO CLINICAL AND BIOLOGICAL MARKERS OF DISEASE ACTIVITY. In GUT Vol. 64 (pp. A241-A242). doi:10.1136/gutjnl-2015-309861.517
GAS CHROMATOGRAPHY SENSOR PLATFORM FOR DIAGNOSING INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME USING FAECAL SAMPLES
Aggio, R., White, P., Costello, B. D. L., Ratcliffe, N., & Probert, C. (2015). GAS CHROMATOGRAPHY SENSOR PLATFORM FOR DIAGNOSING INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME USING FAECAL SAMPLES. In GUT Vol. 64 (pp. A53-A54). doi:10.1136/gutjnl-2015-309861.107
HYPERVIRULENT CLOSTRIDIUM DIFFICILE HAS A UNIQUE ODOUR PROFILE
Reade, S., Simpson, H., Aggio, R. B. M., & Probert, C. S. J. (2015). HYPERVIRULENT CLOSTRIDIUM DIFFICILE HAS A UNIQUE ODOUR PROFILE. In GUT Vol. 64 (pp. A158). doi:10.1136/gutjnl-2015-309861.332
INVESTIGATION OF FAECAL VOLATILE ORGANIC COMPOUNDS AS BIOMARKERS FOR THE DIAGNOSIS OF NECROTISING ENTERCOLITIS
Mayor, A., Ellaby, N., Reade, S., Aggio, R., Greenwood, R., Jackson, R., . . . Ewer, A. K. (2015). INVESTIGATION OF FAECAL VOLATILE ORGANIC COMPOUNDS AS BIOMARKERS FOR THE DIAGNOSIS OF NECROTISING ENTERCOLITIS. Retrieved from https://www.webofscience.com/
INVESTIGATION OF VOLATILE ORGANIC COMPOUNDS EMITTED FROM FAECES FOR THE DIAGNOSIS OF GIARDIASIS
Bond, A., Vernon, A., Reade, S., Mayor, A., Wastling, J., Minetti, C., . . . Probert, C. (2015). INVESTIGATION OF VOLATILE ORGANIC COMPOUNDS EMITTED FROM FAECES FOR THE DIAGNOSIS OF GIARDIASIS. In GUT Vol. 64 (pp. A288). doi:10.1136/gutjnl-2015-309861.620
PATIENTS RECEIVING ANTI-TNF AGENTS FOR INFLAMMATORY BOWEL DISEASE: EXPOSURE TO DIAGNOSTIC IONISING RADIATION AND TRENDS IN IMAGING MODALITIES
Meredith, S., Dibb, M., Ellis, T., Gordon, M., Probert, C., Subramanian, S., & Collins, P. (2015). PATIENTS RECEIVING ANTI-TNF AGENTS FOR INFLAMMATORY BOWEL DISEASE: EXPOSURE TO DIAGNOSTIC IONISING RADIATION AND TRENDS IN IMAGING MODALITIES. In GUT Vol. 64 (pp. A437). doi:10.1136/gutjnl-2015-309861.958
QUALITY OF CARE IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: HOW DO PATIENTS RATE THEIR QUALITY OF CARE?
Ding, W. Y., Baigent, A., Bunger, K., Dibb, M., Ellis, T., Gordon, M., . . . Collins, P. (2015). QUALITY OF CARE IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: HOW DO PATIENTS RATE THEIR QUALITY OF CARE?. In GUT Vol. 64 (pp. A209-A210). doi:10.1136/gutjnl-2015-309861.449
RESILIENCE AND PROTECTION AGAINST THE DOSE-RELATED TOXICITY OF HYDROGEN SULPHIDE
Sawbridge, D., Wilson, J., & Probert, C. (2015). RESILIENCE AND PROTECTION AGAINST THE DOSE-RELATED TOXICITY OF HYDROGEN SULPHIDE. In GUT Vol. 64 (pp. A364). doi:10.1136/gutjnl-2015-309861.796
THE INFLUENCE OF IRON SUPPLEMENTATION ON THE SEVERITY OF A MURINE MODEL OF COLITIS
Mahalhal, A., Reade, S., Campbell, B., Pritchard, D. M., & Probert, C. (2015). THE INFLUENCE OF IRON SUPPLEMENTATION ON THE SEVERITY OF A MURINE MODEL OF COLITIS. In GUT Vol. 64 (pp. A92). doi:10.1136/gutjnl-2015-309861.187
URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC)
Bond, A., Aggio, R., Johnson, P., Berhane, S., & Probert, C. (2015). URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC). In GUT Vol. 64 (pp. A462). doi:10.1136/gutjnl-2015-309861.1011
VOLATILE ORGANIC COMPOUND (VOC) PROFILES AS INDICATORS OF EARLY LESIONS IN MURINE COLON CARCINOGENESIS
Reade, S., Williams, J. M., Pritchard, D. M., & Probert, C. S. J. (2015). VOLATILE ORGANIC COMPOUND (VOC) PROFILES AS INDICATORS OF EARLY LESIONS IN MURINE COLON CARCINOGENESIS. In GUT Vol. 64 (pp. A374-A375). doi:10.1136/gutjnl-2015-309861.819
Resilience and protection against the dose-related toxicity of hydrogen sulphide
Sawbridge, D., Wilson, J., & Probert, C. (2015). Resilience and protection against the dose-related toxicity of hydrogen sulphide. In NITRIC OXIDE-BIOLOGY AND CHEMISTRY Vol. 47 (pp. S17). doi:10.1016/j.niox.2015.02.041
Mo1816 The Impact of NOD2 Variants on Gut Microbiota in Crohn's Disease and Healthy Controls
Kennedy, N. A., Walker, A. W., Berry, S. H., Lamb, C. A., Lewis, S., Mansfield, J. C., . . . Lees, C. W. (2015). Mo1816 The Impact of NOD2 Variants on Gut Microbiota in Crohn's Disease and Healthy Controls. Gastroenterology, 148(4), S-718. doi:10.1016/s0016-5085(15)32446-x
Review article: cytomegalovirus and inflammatory bowel disease
Sager, K., Alam, S., Bond, A., Chinnappan, L., & Probert, C. S. (2015). Review article: cytomegalovirus and inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 41(8), 725-733. doi:10.1111/apt.13124
Diverticular disease
Gaglia, A., & Probert, C. S. (2015). Diverticular disease. Medicine, 43(6), 320-323. doi:10.1016/j.mpmed.2015.03.002
European evidence based consensus on surgery for ulcerative colitis
Oresland, T., Bemelman, W. A., Sampietro, G. M., Spinelli, A., Windsor, A., Ferrante, M., . . . D'Hoore, A. (2015). European evidence based consensus on surgery for ulcerative colitis. JOURNAL OF CROHNS & COLITIS, 9(1), 4-25. doi:10.1016/j.crohns.2014.08.012
The Impact of NOD2 Variants on Gut Microbiota in Crohn's Disease and Healthy Controls
Kennedy, N. A., Walker, A. W., Berry, S. H., Lamb, C. A., Lewis, S., Mansfield, J. C., . . . Lees, C. W. (2015). The Impact of NOD2 Variants on Gut Microbiota in Crohn's Disease and Healthy Controls. In GASTROENTEROLOGY Vol. 148 (pp. S718). Retrieved from https://www.webofscience.com/
The use of randomisation-based efficacy estimators in non-inferiority trials
Gillespie, D., Hood, K., Farewell, D., Hawthorne, A., Probert, C., Stenson, R., . . . Murray, N. (2015). The use of randomisation-based efficacy estimators in non-inferiority trials. Trials, 16(Suppl 2), P129.
2014
Identifying and quantifying metabolites by scoring peaks of GC-MS data
Aggio, R. B. M., Mayor, A., Reade, S., Probert, C. S. J., & Ruggiero, K. (2014). Identifying and quantifying metabolites by scoring peaks of GC-MS data. BMC BIOINFORMATICS, 15. doi:10.1186/s12859-014-0374-2
A METABOLOMIC PROFILING STUDY OF A CHEMICALLY-INDUCED MOUSE MODEL OF INTESTINAL INFLAMMATION
Reade, S., Duckworth, C. A., Khalid, T., Mayor, A., Aggio, R., Pritchard, D. M., & Probert, C. S. (2014). A METABOLOMIC PROFILING STUDY OF A CHEMICALLY-INDUCED MOUSE MODEL OF INTESTINAL INFLAMMATION. In GUT Vol. 63 (pp. A172). doi:10.1136/gutjnl-2014-307263.369
A rare cause of weight loss
Flanagan, P. K., Coupland, S. E., Arumainathan, A., & Probert, C. S. J. (2014). A rare cause of weight loss. GUT, 63(6), 1024-1025. doi:10.1136/gutjnl-2013-306299
INCREASING WEIGHT AND BODY MASS INDEX ADVERSELY AFFECT THIOGUANINE NUCLEOTIDE LEVELS IN INFLAMMATORY BOWEL DISEASE
Subramanian, S., Poon, S., Kneebone, A., Asher, R., Jackson, R., Gregg, B., . . . Dibb, M. (2014). INCREASING WEIGHT AND BODY MASS INDEX ADVERSELY AFFECT THIOGUANINE NUCLEOTIDE LEVELS IN INFLAMMATORY BOWEL DISEASE. In GUT Vol. 63 (pp. A168). doi:10.1136/gutjnl-2014-307263.360
MEAN CORPUSCULAR VOLUME BUT NOT LYMPHOCYTE COUNT IS A PREDICTOR OF THIOPURINE DOSE ADEQUACY AND TOXICITY
Kneebone, A., Poon, S. S., Asher, R., Jackson, R., Gregg, B., Kerr, S., . . . Dibb, M. (2014). MEAN CORPUSCULAR VOLUME BUT NOT LYMPHOCYTE COUNT IS A PREDICTOR OF THIOPURINE DOSE ADEQUACY AND TOXICITY. In GUT Vol. 63 (pp. A157-A158). doi:10.1136/gutjnl-2014-307263.338
PAEDIATRIC FAECAL VOC ANALYSIS: METHOD OPTIMISATION
Mayor, A., Reade, S., Aggio, R., Khalid, T., & Probert, C. (2014). PAEDIATRIC FAECAL VOC ANALYSIS: METHOD OPTIMISATION. In GUT Vol. 63 (pp. A218). doi:10.1136/gutjnl-2014-307263.469
PWE-109 A Metabolomic Profiling Study Of A Chemically-induced Mouse Model Of Intestinal Inflammation
Reade, S., Duckworth, C. A., Khalid, T., Mayor, A., Aggio, R., Pritchard, D. M., & Probert, C. S. (2014). PWE-109 A Metabolomic Profiling Study Of A Chemically-induced Mouse Model Of Intestinal Inflammation. In Gut Vol. 63 (pp. A172).
Population-based Screening in Colorectal Cancer - Current Practice and Future Developments: Faecal Biomarkers Review
Sawbridge, D., & Probert, C. (2014). Population-based Screening in Colorectal Cancer - Current Practice and Future Developments: Faecal Biomarkers Review. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 23(2), 195-202. Retrieved from https://www.webofscience.com/
THE IMPACT OF NOD2 VARIANTS ON GUT MICROBIOTA IN CROHN'S DISEASE AND HEALTHY CONTROLS
Kennedy, N. A., Walker, A. W., Berry, S. H., Lamb, C. A., Lewis, S., Mansfield, J., . . . Lees, C. W. (2014). THE IMPACT OF NOD2 VARIANTS ON GUT MICROBIOTA IN CROHN'S DISEASE AND HEALTHY CONTROLS. In GUT Vol. 63 (pp. A159-S160). doi:10.1136/gutjnl-2014-307263.342
Towards point of care testing for <i>C</i>. <i>difficile</i> infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection
McGuire, N. D., Ewen, R. J., Costello, B. D. L., Garner, C. E., Probert, C. S. J., Vaughan, K., & Ratcliffe, N. M. (2014). Towards point of care testing for <i>C</i>. <i>difficile</i> infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection. MEASUREMENT SCIENCE AND TECHNOLOGY, 25(6). doi:10.1088/0957-0233/25/6/065108
676 Urinary volatile organic compounds: Novel approach to rapid UTI diagnosis
Johnson, E. U., Probert, C. S. J., Persad, R., Khalid, T., & Ratcliffe, N. (2014). 676 Urinary volatile organic compounds: Novel approach to rapid UTI diagnosis. European Urology Supplements, 13(1), e676. doi:10.1016/s1569-9056(14)60666-7
Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life
Probert, C. S. J., Dignass, A. U., Lindgren, S., Pool, M. O., & Marteau, P. (2014). Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life. JOURNAL OF CROHNS & COLITIS, 8(3), 200-207. doi:10.1016/j.crohns.2013.08.007
The Liver Breath! Breath Volatile Organic Compounds for the Diagnosis of Liver Disease
Khalid, T., Richardson, P., & Probert, C. S. (2014). The Liver Breath! Breath Volatile Organic Compounds for the Diagnosis of Liver Disease. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(3), 524-526. doi:10.1016/j.cgh.2013.10.032
Early Use of Azathioprine in Crohn's Disease
Hawthorne, A. B., Probert, C. S. J., & Sanderson, J. D. (2014). Early Use of Azathioprine in Crohn's Disease. GASTROENTEROLOGY, 146(3), 866-+. doi:10.1053/j.gastro.2013.10.072
Effect of "acid protect" supplementation on the volatile faecal metabolome of thoroughbred racehorses
Larkins, N., Proudman, C. J., Travers, J., Probert, C. J., & Koare, K. (2014). Effect of "acid protect" supplementation on the volatile faecal metabolome of thoroughbred racehorses. In IMMUNOLOGY Vol. 143 (pp. 20). Retrieved from https://www.webofscience.com/
Electronic Monitoring of Medication Adherence in a 1-year Clinical Study of 2 Dosing Regimens of Mesalazine for Adults in Remission with Ulcerative Colitis
Gillespie, D., Hood, K., Farewell, D., Stenson, R., Probert, C., & Hawthorne, A. B. (2014). Electronic Monitoring of Medication Adherence in a 1-year Clinical Study of 2 Dosing Regimens of Mesalazine for Adults in Remission with Ulcerative Colitis. INFLAMMATORY BOWEL DISEASES, 20(1), 82-91. doi:10.1097/01.MIB.0000437500.60546.2a
Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease?
Probert, C. S. J., Reade, S., & Ahmed, I. (2014). Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease?. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 10(9), 1129-1131. doi:10.1586/1744666X.2014.943664
Future Methods for the Diagnosis of Inflammatory Bowel Disease
Aggio, R., & Probert, C. (2014). Future Methods for the Diagnosis of Inflammatory Bowel Disease. DIGESTIVE DISEASES, 32(4), 463-467. doi:10.1159/000358153
The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients
Shepherd, S. F., McGuire, N. D., de Lacy Costello, B. P. J., Ewen, R. J., Jayasena, D. H., Vaughan, K., . . . Ratcliffe, N. M. (2014). The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients. JOURNAL OF BREATH RESEARCH, 8(2). doi:10.1088/1752-7155/8/2/026001
2013
Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study
Khalid, T. Y., Costello, B. D. L., Ewen, R., White, P., Stevens, S., Gordon, F., . . . Probert, C. S. (2013). Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study. METABOLOMICS, 9(5), 938-948. doi:10.1007/s11306-013-0510-4
New insights on fibrosis in Crohn's disease
Bailey, J. R., Whiting, C. V., Tarlton, J. F., Bland, P. W., & Probert, C. S. J. (2013). New insights on fibrosis in Crohn's disease. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 7(6), 497-499. doi:10.1586/17474124.2013.814931
A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace
Khalid, T., White, P., Costello, B. D. L., Persad, R., Ewen, R., Johnson, E., . . . Ratcliffe, N. (2013). A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace. PLOS ONE, 8(7). doi:10.1371/journal.pone.0069602
ACCURACY OF SIMTOMAX RAPID COELIAC SCREENING TEST COMPARED WITH ELISA TTG ASSAY AND DUODENAL BIOPSY
McClements, D., Rivera-Forrester, R., Horsted, F., Murphy, C., Probert, C., & Subramanian, S. (2013). ACCURACY OF SIMTOMAX RAPID COELIAC SCREENING TEST COMPARED WITH ELISA TTG ASSAY AND DUODENAL BIOPSY. In GUT Vol. 62 (pp. A126). doi:10.1136/gutjnl-2013-304907.279
CHARTING THE VOLATILE ORGANIC METABOLOME (VOM): A COMPARISON OF MURINE AND HUMAN FAECES
Sawbridge, D., Reade, S., Khalid, T., & Probert, C. (2013). CHARTING THE VOLATILE ORGANIC METABOLOME (VOM): A COMPARISON OF MURINE AND HUMAN FAECES. In GUT Vol. 62 (pp. A134). doi:10.1136/gutjnl-2013-304907.300
PTH-025 Sniffing Disease? Optimisation of Sample Preparation for Volalite Organic Metabolomic Studies
Reade, S., Sawbridge, D., Khalid, T., & Probert, C. (2013). PTH-025 Sniffing Disease? Optimisation of Sample Preparation for Volalite Organic Metabolomic Studies. Gut, 62(Suppl 1), A221.2-A222. doi:10.1136/gutjnl-2013-304907.513
PTU-058 One Year Likelihood of Relapse in Ulcerative Colitis (UC) is Predicted by Mucosal Appearance but not by Faecal Calprotectin: Data from the Coda Study of once Daily Versus Three Times Daily Asacol
Hawthorne, A. B., Gillespie, D., & Probert, C. (2013). PTU-058 One Year Likelihood of Relapse in Ulcerative Colitis (UC) is Predicted by Mucosal Appearance but not by Faecal Calprotectin: Data from the Coda Study of once Daily Versus Three Times Daily Asacol. Gut, 62(Suppl 1), A68.1-A68. doi:10.1136/gutjnl-2013-304907.150
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
Flourie, B., Hagege, H., Tucat, G., Maetz, D., Hebuterne, X., Kuyvenhoven, J. P., . . . Aoucheta, D. (2013). Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 37(8), 767-775. doi:10.1111/apt.12266
Difference in Yield and Physiological Features in Response to Drought and Salinity Combined Stress during Anthesis in Tibetan Wild and Cultivated Barleys
Ahmed, I. M., Cao, F., Zhang, M., Chen, X., Zhang, G., & Wu, F. (2013). Difference in Yield and Physiological Features in Response to Drought and Salinity Combined Stress during Anthesis in Tibetan Wild and Cultivated Barleys. PLOS ONE, 8(10). doi:10.1371/journal.pone.0077869
Volatiles from oral anaerobes confounding breath biomarker discovery
Khalid, T. Y., Saad, S., Greenman, J., Costello, B. D. L., Probert, C. S. J., & Ratcliffe, N. M. (2013). Volatiles from oral anaerobes confounding breath biomarker discovery. JOURNAL OF BREATH RESEARCH, 7(1). doi:10.1088/1752-7155/7/1/017114
P562 Comparing the efficacy of once-daily or twice-daily mesalazine dosing in the treatment of left-sided ulcerative colitis versus the overall MOTUS study population
Flourié, B., Kuyvenhoven, J., Probert, C., & Dewit, O. (2013). P562 Comparing the efficacy of once-daily or twice-daily mesalazine dosing in the treatment of left-sided ulcerative colitis versus the overall MOTUS study population. Journal of Crohn's and Colitis, 7, S236. doi:10.1016/s1873-9946(13)60583-8
Best of Five MCQs for the Gastroenterology SCE
Rutter, C., Griffiths, L., Mehta, T., & Probert, C. (Eds.) (2013). Best of Five MCQs for the Gastroenterology SCE. Oxford: Oxford University Press.
Comparison of a Frozen Human Foreskin Fibroblast Cell Assay to an Enzyme Immunoassay and Toxigenic Culture for the Detection of Toxigenic Clostridium difficile
Strachan, A. J., Evans, N. E., & Probert, C. J. (2013). Comparison of a Frozen Human Foreskin Fibroblast Cell Assay to an Enzyme Immunoassay and Toxigenic Culture for the Detection of Toxigenic Clostridium difficile. Diagnostic Microbiology & Infectious Disease, 75(1), 42-45. doi:10.1016/j.diagmicrobio.2012.09.0
Difference in yield and physiological features in response to drought and salinity combined stress during anthesis in Tibetan wild and cultivated barleys.
Ahmed, I. M., Cao, F., Zhang, M., Chen, X., Zhang, G., & Wu, F. (2013). Difference in yield and physiological features in response to drought and salinity combined stress during anthesis in Tibetan wild and cultivated barleys.. PloS one, 8(10), e77869. doi:10.1371/journal.pone.0077869
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., . . . Rioux, K. P. (2013). Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 11(7), 868-+. doi:10.1016/j.cgh.2013.02.015
Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma
Probert, C. (2013). Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 6(1), 33-38. doi:10.1177/1756283X12461395
2012
IL-13 Promotes Collagen Accumulation in Crohn's Disease Fibrosis by Down-Regulation of Fibroblast MMP Synthesis: A Role for Innate Lymphoid Cells?
Bailey, J. R., Bland, P. W., Tarlton, J. F., Peters, I., Moorghen, M., Sylvester, P. A., . . . Whiting, C. V. (2012). IL-13 Promotes Collagen Accumulation in Crohn's Disease Fibrosis by Down-Regulation of Fibroblast MMP Synthesis: A Role for Innate Lymphoid Cells?. PLOS ONE, 7(12). doi:10.1371/journal.pone.0052332
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
Dhanda, A. D., Creed, T. J., Greenwood, R., Sands, B. E., & Probert, C. S. (2012). Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?. INFLAMMATORY BOWEL DISEASES, 18(11), 2056-2062. doi:10.1002/ibd.22879
One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis
Hawthorne, A. B., Stenson, R., Gillespie, D., Swarbrick, E. T., Dhar, A., Kapur, K. C., . . . Probert, C. S. J. (2012). One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis. INFLAMMATORY BOWEL DISEASES, 18(10), 1885-1893. doi:10.1002/ibd.21938
PMO-259 Predicting failure of medical management in IBD patients- data from the 3rd round UK IBD audit: Abstract PMO-259 Table 1
Walker, G., Greenwood, R., Arnott, I., & Probert, C. (2012). PMO-259 Predicting failure of medical management in IBD patients- data from the 3rd round UK IBD audit: Abstract PMO-259 Table 1. Gut, 61(Suppl 2), A181.1-A181. doi:10.1136/gutjnl-2012-302514b.259
PMO-260 Bone protection is under used in IBD patients: data from the 3rd round UK IBD audit
Walker, G., Arnott, I., & Probert, C. (2012). PMO-260 Bone protection is under used in IBD patients: data from the 3rd round UK IBD audit. Gut, 61(Suppl 2), A181.2-A181. doi:10.1136/gutjnl-2012-302514b.260
PMO-261 Is Crohn's disease in the UK being under treated? Data from the 3rd round UK IBD audit: Abstract PMO-261 Table 1
Walker, G., Arnott, I., & Probert, C. (2012). PMO-261 Is Crohn's disease in the UK being under treated? Data from the 3rd round UK IBD audit: Abstract PMO-261 Table 1. Gut, 61(Suppl 2), A181.3-A182. doi:10.1136/gutjnl-2012-302514b.261
PWE-169 Analysis of faecal volatiles from young children infected with and without rotavirus: Abstract PWE-169 Figure 1
Al-Kateb, H., Cunliffe, N., deLacy Costello, B., Probert, C., & Ratcliffe, N. (2012). PWE-169 Analysis of faecal volatiles from young children infected with and without rotavirus: Abstract PWE-169 Figure 1. Gut, 61(Suppl 2), A364.3-A365. doi:10.1136/gutjnl-2012-302514d.169
PWE-230 An iron-responsive probiotic to treat inflammatory bowel disease
Bailey, J., Probert, C., & Cogan, T. (2012). PWE-230 An iron-responsive probiotic to treat inflammatory bowel disease. Gut, 61(Suppl 2), A391.3-A392. doi:10.1136/gutjnl-2012-302514d.230
Mixed fortunes in the treatment of Crohn's disease
Walker, G., Venkatachalam, P., Bird, J., Wilson, D., & Probert, C. (2012). Mixed fortunes in the treatment of Crohn's disease. LANCET, 379(9832), 2212. doi:10.1016/S0140-6736(12)60359-6
1097 Once-Daily Versus Twice-Daily Mesalazine for Active Ulcerative Colitis: Efficacy Results From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study
Flourie, B., Hagege, H., Tucat, G., Masclee, A., Dewit, O., Probert, C., . . . Djamila, A. (2012). 1097 Once-Daily Versus Twice-Daily Mesalazine for Active Ulcerative Colitis: Efficacy Results From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study. Gastroenterology, 142(5), S-197. doi:10.1016/s0016-5085(12)60740-9
1098 Once-Daily Versus Twice-Daily Mesalazine for Mild to Moderately Active Ulcerative Colitis: Mucosal Healing and Early Response Data From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study
Pierik, M. J., Flourie, B., Hagege, H., Tucat, G., Masclee, A., Dewit, O., . . . Djamila, A. (2012). 1098 Once-Daily Versus Twice-Daily Mesalazine for Mild to Moderately Active Ulcerative Colitis: Mucosal Healing and Early Response Data From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study. Gastroenterology, 142(5), S-198. doi:10.1016/s0016-5085(12)60741-0
P183 Once-daily versus twice-daily mesalazine for active ulcerative colitis: Efficacy results from MOTUS, a multicentre, controlled, randomised, investigator-blinded study
Flourié, B., Hagége, H., Tucat, G., Masclee, A., Dewit, O., Probert, C., . . . Aoucheta, D. (2012). P183 Once-daily versus twice-daily mesalazine for active ulcerative colitis: Efficacy results from MOTUS, a multicentre, controlled, randomised, investigator-blinded study. Journal of Crohn's and Colitis, 6, S82. doi:10.1016/s1873-9946(12)60203-7
P184 Once-daily versus twice-daily mesalazine for mild to moderately active ulcerative colitis: Mucosal healing and early response data from MOTUS, a multicentre, controlled, randomised, investigator-blinded study
Pierik, M., Hagége, H., Tucat, G., Masclee, A., Dewit, O., Probert, C., . . . Aoucheta, D. (2012). P184 Once-daily versus twice-daily mesalazine for mild to moderately active ulcerative colitis: Mucosal healing and early response data from MOTUS, a multicentre, controlled, randomised, investigator-blinded study. Journal of Crohn's and Colitis, 6, S82-S83. doi:10.1016/s1873-9946(12)60204-9
Which Extraintestinal Manifestations of IBD Respond to Biologics?
Mehta, T. A., & Probert, C. S. J. (2011). Which Extraintestinal Manifestations of IBD Respond to Biologics?. In Unknown Book (pp. 129-132). Wiley. doi:10.1002/9781444342574.ch28
Prevalence of Different Subtypes of Serrated Polyps and Risk of Synchronous Advanced Colorectal Neoplasia in Average-Risk Population Undergoing First-Time Colonoscopy
Buda, A., De Bona, M., Dotti, I., Piselli, P., Zabeo, E., Barbazza, R., . . . De Boni, M. (2012). Prevalence of Different Subtypes of Serrated Polyps and Risk of Synchronous Advanced Colorectal Neoplasia in Average-Risk Population Undergoing First-Time Colonoscopy. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 3. doi:10.1038/ctg.2011.5
Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid-Refractory Ulcerative Colitis
Sands, B. E., Sandborn, W. J., Creed, T. J., Dayan, C. M., Dhanda, A. D., Van Assche, G. A., . . . Probert, C. S. (2012). Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid-Refractory Ulcerative Colitis. GASTROENTEROLOGY, 143(2), 356-+. doi:10.1053/j.gastro.2012.04.043
Diagnosis of bladder cancer from urinary volatile biomarker
Khalid, T. Y., Ratcliffe, N. M., & Probert, C. S. (2012). Diagnosis of bladder cancer from urinary volatile biomarker. Cancer.
Impact of Coeliac Disease on the Partner’s diet- No Altruism
Hettiarachchi, I. T., & Rowbotham, D. (2012). Impact of Coeliac Disease on the Partner’s diet- No Altruism. Journal of Nutrition & Food Sciences, 02(03). doi:10.4172/2155-9600.1000135
Prevention of postoperative recurrence of Crohn's disease
Ayres, L. O. R., & Probert, C. S. J. (2012). Prevention of postoperative recurrence of Crohn's disease. In A. Hart, & S. W. Ng (Eds.), Inflammatory Bowel Disease: An Evidence-based Practical Guide (pp. 119-132). Tarxien: Gutenberg Presss Ltd.
2011
Identification and Characterisation of an Iron-Responsive Candidate Probiotic
Bailey, J. R., Probert, C. S. J., & Cogan, T. A. (2011). Identification and Characterisation of an Iron-Responsive Candidate Probiotic. PLOS ONE, 6(10). doi:10.1371/journal.pone.0026507
Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease?
Cooper, M. S., Kriel, H., Sayers, A., Fraser, W. D., Williams, A. M., Stewart, P. M., . . . Tobias, J. H. (2011). Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease?. CALCIFIED TISSUE INTERNATIONAL, 89(3), 246-251. doi:10.1007/s00223-011-9512-2
Role of faecal gas analysis for the diagnosis of IBD
Probert, C. S. J. (2011). Role of faecal gas analysis for the diagnosis of IBD. BIOCHEMICAL SOCIETY TRANSACTIONS, 39, 1079-1080. doi:10.1042/BST0391079
The Molecular Biology of Inflammatory Bowel Diseases
Corfield, A. P., Wallace, H. M., & Probert, C. S. J. (2011). The Molecular Biology of Inflammatory Bowel Diseases. BIOCHEMICAL SOCIETY TRANSACTIONS, 39, 1057-1060. doi:10.1042/BST0391057
'Which EIMs respond to biologics?'
Metha, T., & Probert, C. (2011). 'Which EIMs respond to biologics?'. In C. Siegel, P. Irving, D. Rampton, & F. Shanahan (Eds.), Clinical Dilemmas in Inflammatory Bowel Disease - New Challenges.. Oxford: Blackwell.
Diverticular disease
Mehta, T. A., & Probert, C. S. (2011). Diverticular disease. Medicine, 39(5), 265-268. doi:10.1016/j.mpmed.2011.02.001
2010
A costly diagnostic failure
Assadsangabi, A., Probert, C. S., & Pope, I. (2010). A costly diagnostic failure. JOURNAL OF FAMILY PRACTICE, 59(11), 624-626. Retrieved from https://www.webofscience.com/
Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome
Christmas, D. M., Badawy, A. A. -B., Hince, D., Davies, S. J. C., Probert, C., Creed, T., . . . Potokar, J. P. (2010). Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome. NUTRITION RESEARCH, 30(10), 678-688. doi:10.1016/j.nutres.2010.09.009
IL-6 May Modulate the Skeletal Response to Glucocorticoids During Exacerbations of Inflammatory Bowel Disease
Kriel, M., Sayers, A., Fraser, W. D., Williams, A. M., Koch, A., Zacharowski, K., . . . Tobias, J. H. (2010). IL-6 May Modulate the Skeletal Response to Glucocorticoids During Exacerbations of Inflammatory Bowel Disease. CALCIFIED TISSUE INTERNATIONAL, 86(5), 375-381. doi:10.1007/s00223-010-9345-4
Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment
Parker, R., Dixit, A., Fraser, A., Creed, T. J., & Probert, C. S. (2010). Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment. POSTGRADUATE MEDICAL JOURNAL, 86(1014), 208-211. doi:10.1136/pgmj.2009.085787
Mortality in ulcerative colitis-what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review.
Falvey, J., Greenwood, R., Creed, T. J., Smithson, J., Sylvester, P., Fraser, A., & Probert, C. S. (2010). Mortality in ulcerative colitis-what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review.. Frontline gastroenterology, 1(1), 35-41. doi:10.1136/fg.2009.000216
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease
Kriel, M. H., Tobias, J. H., Creed, T. J., Lockett, M., Linehan, J., Bell, A., . . . Probert, C. S. J. (2010). Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease. OSTEOPOROSIS INTERNATIONAL, 21(3), 507-513. doi:10.1007/s00198-009-0960-8
Application of Similarity Coefficients to Predict Disease Using Volatile Organic Compounds
Smith, S., White, P., Redding, J., Ratcliffe, N. M., & Probert, C. S. J. (2010). Application of Similarity Coefficients to Predict Disease Using Volatile Organic Compounds. IEEE SENSORS JOURNAL, 10(1), 92-96. doi:10.1109/JSEN.2009.2035771
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine
Munkholm, P., Michetti, P., Probert, C. S., Elkjaer, M., & Marteau, P. (2010). Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 22(8), 912-916. doi:10.1097/MEG.0b013e32833944bf
2009
Volatile Organic Compounds as Diagnostic Biomarkers in Gastrointestinal and Liver Diseases
Probert, C. S. J., Ahmed, I., Khalid, T., Johnson, E., Smith, S., & Ratcliffe, N. (2009). Volatile Organic Compounds as Diagnostic Biomarkers in Gastrointestinal and Liver Diseases. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 18(3), 337-343. Retrieved from https://www.webofscience.com/
A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis
Garner, C. E., Smith, S., Bardhan, P. K., Ratcliffe, N. M., & Probert, C. S. J. (2009). A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 103(11), 1171-1173. doi:10.1016/j.trstmh.2009.02.004
Analysis of Faecal Volatile Organic Compounds in Preterm Infants Who Develop Necrotising Enterocolitis: A Pilot Study
Garner, C. E., Ewer, A. K., Elasouad, K., Power, F., Greenwood, R., Ratcliffe, N. M., . . . Probert, C. S. (2009). Analysis of Faecal Volatile Organic Compounds in Preterm Infants Who Develop Necrotising Enterocolitis: A Pilot Study. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 49(5), 559-565. doi:10.1097/MPG.0b013e3181a3bfbc
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial
Connolly, M. P., Nielsen, S. K., Currie, C. J., Marteau, P., Probert, C. S. J., & Travis, S. P. L. (2009). An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial. JOURNAL OF CROHNS & COLITIS, 3(3), 168-174. doi:10.1016/j.crohns.2009.02.005
P271 - Interactions between pro-inflammatory cytokines and IL-13 during the development of intestinal strictures
Bailey, J. R., Tarlton, J. F., Probert, C. S. J., Bland, P. W., & Whiting, C. V. (2009). P271 - Interactions between pro-inflammatory cytokines and IL-13 during the development of intestinal strictures. Journal of Crohn's and Colitis, 3(1), S117-S118. doi:10.1016/s1873-9946(09)60298-1
P287 - Factors promoting inflammation-induced fibrosis in Crohn's disease
Whiting, C. V., Bailey, J. R., Tarlton, J. F., Probert, C. S. J., & Bland, P. W. (2009). P287 - Factors promoting inflammation-induced fibrosis in Crohn's disease. Journal of Crohn's and Colitis, 3(1), S123-S124. doi:10.1016/s1873-9946(09)60314-7
P291 - IL-2 enhances the in vitro proliferation of T cells from patients with IBD but does not influence in vitro steroid resistance
Williams, A. M., Probert, C. S. J., Creed, T. J., & DiMambro, A. J. (2009). P291 - IL-2 enhances the in vitro proliferation of T cells from patients with IBD but does not influence in vitro steroid resistance. Journal of Crohn's and Colitis, 3(1), S125. doi:10.1016/s1873-9946(09)60318-4
Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge
Shufflebotham, J., Wetherell, M. A., Hince, D., Hood, S., Lightman, S., Nutt, D., . . . Potokar, J. (2009). Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 12(1), 30-36. doi:10.1080/10253890801976926
2008
SCHU-03: Novel Biomarkers in Prostate Cancer Detection
Johnson, E., Smith, S., Probert, C., Ratcliffe, N., & Persad, R. (2008). SCHU-03: Novel Biomarkers in Prostate Cancer Detection. Urology, 72(5), S3. doi:10.1016/j.urology.2008.08.009
Irritable Bowel Syndrome Patients Exhibit Depressive and Anxiety Scores in the Subsyndromal Range
Hood, S. D., Shufflebotham, J. Q., Hendry, J., Hince, D. A., Rich, A. S., Probert, C. S. J., & Potokar, J. (2008). Irritable Bowel Syndrome Patients Exhibit Depressive and Anxiety Scores in the Subsyndromal Range. The Open Psychiatry Journal, 2(1), 12-22. doi:10.2174/1874354400802010012
Are there any ethnic groups that are more likely to develop IBD?
Probert, C. S., & Brown, M. (2008). Are there any ethnic groups that are more likely to develop IBD?. Inflammatory Bowel Diseases, 14(Supplement), S24-S25. doi:10.1097/00054725-200810001-00012
Basiliximab and Infliximab for the Treatment of Steroid-Refractory Crohn's Disease
Price, M., Probert, C. S. J., & Creed, T. (2008). Basiliximab and Infliximab for the Treatment of Steroid-Refractory Crohn's Disease. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(10), 2665. Retrieved from https://www.webofscience.com/
Is once-daily dosing of mesalazine effective for maintenance of remission in patients with ulcerative colitis?
Probert, C. S. J. (2008). Is once-daily dosing of mesalazine effective for maintenance of remission in patients with ulcerative colitis?. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 5(11), 596-597. doi:10.1038/ncpgasthep1255
A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry
Smith, S., Burden, H., Persad, R., Whittington, K., Costello, B. D. L., Ratcliffe, N. M., & Probert, C. S. (2008). A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry. JOURNAL OF BREATH RESEARCH, 2(3). doi:10.1088/1752-7155/2/3/037022
An analysis of volatiles in the headspace of the faeces of neonates
Costello, B. D. L., Ewen, R., Ewer, A. K., Garner, C. E., Probert, C. S. J., Ratcliffe, N. M., & Smith, S. (2008). An analysis of volatiles in the headspace of the faeces of neonates. JOURNAL OF BREATH RESEARCH, 2(3). doi:10.1088/1752-7155/2/3/037023
Identification of <i>Campylobacter</i> infection in chickens from volatile faecal emissions
Garner, C. E., Smith, S., Elviss, N. C., Humphrey, T. J., White, P., Ratcliffe, N. M., & Probert, C. S. (2008). Identification of <i>Campylobacter</i> infection in chickens from volatile faecal emissions. BIOMARKERS, 13(4), 413-421. doi:10.1080/13547500801966443
Are There Any Ethnic Groups That Are More Likely to Develop IBD?
Probert, C. S., & Brown, M. (2008). Are There Any Ethnic Groups That Are More Likely to Develop IBD?. INFLAMMATORY BOWEL DISEASES, 14, S24-S25. doi:10.1002/ibd.20601
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome
Shah, J. A., Edwards, C. M., & Probert, C. S. (2008). Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 20(3), 169-173. doi:10.1097/MEG.0b013e3282f16d50
2007
T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking
Brooklyn, T. N., Williams, A. M., Dunnill, M. G. S., & Probert, C. S. (2007). T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking. BRITISH JOURNAL OF DERMATOLOGY, 157(5), 960-966. doi:10.1111/j.1365-2133.2007.08211.x
A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease
Mansfield, J. C., Parkes, M., Hawthorne, A. B., Forbes, A., Probert, C. S. J., Perowne, R. C., . . . Hawkey, C. J. (2007). A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 26(3), 421-430. doi:10.1111/j.1365-2036.2007.03385.x
Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease: authors' reply
Creed, T. J., & Probert, C. (2007). Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease: authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 25(11), 1364. doi:10.1111/j.1365-2036.2007.03321.x
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
Garner, C. E., Smith, S., Costello, B. D. L., White, P., Spencer, R., Probert, C. S. J., & Ratcliffe, N. M. (2007). Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB JOURNAL, 21(8), 1675-1688. doi:10.1096/fj.06-6927com
A case-control study of drinking water and dairy products in Crohn's disease- Further investigation of the possible role of mycobacterium avium paratuberculosis
Abubakar, I., Myhill, D. J., Hart, A. R., Lake, I. R., Harvey, I., Rhodes, J. M., . . . Hunter, P. R. (2007). A case-control study of drinking water and dairy products in Crohn's disease- Further investigation of the possible role of mycobacterium avium paratuberculosis. AMERICAN JOURNAL OF EPIDEMIOLOGY, 165(7), 776-783. doi:10.1093/aje/kwk067
Repertoire of the αβ T-cell receptor in the intestine
Probert, C. S. J., Saubermann, L. J., Balk, S., & Blumberg, R. S. (2007). Repertoire of the αβ T-cell receptor in the intestine. IMMUNOLOGICAL REVIEWS, 215, 215-225. doi:10.1111/j.1600-065X.2006.00480.x
Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies
Creed, T. J., & Probert, C. S. J. (2007). Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 25(2), 111-122. doi:10.1111/j.1365-2036.2006.03156.x
Diverticular disease
Kriel, H., & Probert, C. S. (2007). Diverticular disease. Medicine, 35(6), 317-319. doi:10.1016/j.mpmed.2007.03.003
Non‐Invasive Diagnosis and Assessment
Mambro, A. J. D., Terlevich, A., & Probert, C. (2006). Non‐Invasive Diagnosis and Assessment. In Unknown Book (pp. 8-10). Wiley. doi:10.1002/9780470750827.ch3
The effect of weaning on the clonality of <i>αβ</i> T-cell receptor T cells in the intestine of GF and SPF mice
Probert, C. S. J., Williams, A. M., Stepankova, R., Tlaskalova-Hogenova, H., Phillips, A., & Bland, P. W. (2007). The effect of weaning on the clonality of <i>αβ</i> T-cell receptor T cells in the intestine of GF and SPF mice. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 31(6), 606-617. doi:10.1016/j.dci.2006.08.008
2006
Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse
Williams, A. M., Probert, C. S. J., Stepankova, R., Tlaskalova-Hogenova, H., Phillips, A., & Bland, P. W. (2006). Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. IMMUNOLOGY, 119(4), 470-478. doi:10.1111/j.1365-2567.2006.02458.x
Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome
Shufflebotham, J., Hood, S., Hendry, J., Hince, D. A., Morris, K., Nutt, D., . . . Potokar, J. (2006). Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. AMERICAN JOURNAL OF GASTROENTEROLOGY, 101(11), 2582-2587. doi:10.1111/j.1572-0241.2006.00811.x
Review article: maintenance therapy in patients with ulcerative colitis
Orchard, T., Probert, C. S., & Keshav, S. (2006). Review article: maintenance therapy in patients with ulcerative colitis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 24, 17-22. doi:10.1111/j.1365-2036.2006.03071.x
Selective processing of gastrointestinal symptom-related stimuli in irritable bowel syndrome
Afzal, M., Potokar, J. P., Probert, C. S. J., & Munafo, M. R. (2006). Selective processing of gastrointestinal symptom-related stimuli in irritable bowel syndrome. PSYCHOSOMATIC MEDICINE, 68(5), 758-761. doi:10.1097/01.psy.0000232270.78071.28
Diagnosis and treatment of pyoderma gangrenosum
Brooklyn, T., Dunnill, G., & Probert, C. (2006). Diagnosis and treatment of pyoderma gangrenosum. BRITISH MEDICAL JOURNAL, 333(7560), 181-184. doi:10.1136/bmj.333.7560.181
Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease
Creed, T. J., Probert, C. S. J., Norman, M. N., Moorghen, M., Shepherd, N. A., Hearing, S. D., & Dayan, C. M. (2006). Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 23(10), 1435-1442. doi:10.1111/j.1365-2036.2006.02904.x
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
Brooklyn, T. N., Dunnill, M. G. S., Shetty, A., Bowden, J. J., Williams, J. D. L., Griffiths, C. E. M., . . . Probert, C. S. (2006). Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. GUT, 55(4), 505-509. doi:10.1136/gut.2005.074815
Biologics in ulcerative colitis
Creed, T. J., & Probert, C. S. J. (n.d.). Biologics in ulcerative colitis. In Falk Symposium (pp. 183-189). Springer Netherlands. doi:10.1007/1-4020-4316-3_19
2005
Infliximab use in Crohn's disease: impact on health care resources in the UK
Jewell, D. R., Satsangi, J., Lobo, A., Probert, C., Forbes, A., Ghosh, S., . . . Buchan, S. (2005). Infliximab use in Crohn's disease: impact on health care resources in the UK. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 17(10), 1047-1052. doi:10.1097/00042737-200510000-00007
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
Marteau, P., Probert, C. S., Lindgren, S., Gassul, M., Tan, T. G., Dignass, A., . . . Foldager, M. (2005). Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. GUT, 54(7), 960-965. doi:10.1136/gut.2004.060103
Refractory coeliac disease: remission with infliximab and immunomodulators
Turner, S. M., Moorghen, M., & Probert, C. S. (2005). Refractory coeliac disease: remission with infliximab and immunomodulators. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 17(6), 667-669. doi:10.1097/00042737-200506000-00012
ERRATUM
ERRATUM (2005). The American Journal of Gastroenterology, 100(1), 255. doi:10.1111/j.1572-0241.2005.20041215.x
Is mesalazine really safe for use in breastfeeding mothers?
Silverman, D. A., Ford, J., Shaw, I., & Probert, C. S. J. (2005). Is mesalazine really safe for use in breastfeeding mothers?. GUT, 54(1), 170-171. doi:10.1136/gut.2004.048058
2004
Intestinal αβ T cells differentiate and rearrange antigen receptor genes in situ in the human infant
Williams, A. M., Bland, P. W., Phillips, A. C., Turner, S., Brooklyn, T., Shaya, G., . . . Probert, C. S. J. (2004). Intestinal αβ T cells differentiate and rearrange antigen receptor genes in situ in the human infant. JOURNAL OF IMMUNOLOGY, 173(12), 7190-7199. doi:10.4049/jimmunol.173.12.7190
Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy
Tobias, J. H., Sasi, M. R., Greenwood, R., & Probert, C. S. J. (2004). Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 20(9), 951-957. doi:10.1111/j.1365-2036.2004.02207.x
Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom.
Tsironi, E., Feakins, R. M., Probert, C. S. J., Rampton, D. S., & Phil, D. (2004). Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom.. The American journal of gastroenterology, 99(9), 1749-1755. doi:10.1111/j.1572-0241.2004.30445.x
Should we monitor vitamin B12 levels in patients who have had end-ileostomy for inflammatory bowel disease?
Jayaprakash, A., Creed, T., Stewart, L., Colton, B., Mountford, R., Standen, G., & Probert, C. (2004). Should we monitor vitamin B12 levels in patients who have had end-ileostomy for inflammatory bowel disease?. International journal of colorectal disease, 19(4), 316-318. doi:10.1007/s00384-003-0556-2
Upper gastrointestinal haemorrhage following cardiac surgery: a comparative study with vascular surgery patients from a single centre
Jayaprakash, A., McGrath, C., McCullagh, E., Smith, F., Angelini, G., & Probert, C. (2004). Upper gastrointestinal haemorrhage following cardiac surgery: a comparative study with vascular surgery patients from a single centre. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 16(2), 191-194. doi:10.1097/00042737-200402000-00011
A novel method for rapidly diagnosing the causes of diarrhoea
Probert, C. S. J., Jones, P. R. H., & Ratcliffe, N. M. (2004). A novel method for rapidly diagnosing the causes of diarrhoea. GUT, 53(1), 58-61. doi:10.1136/gut.53.1.58
2003
Erratum: Traditional finals and OSCEs in predicting consultant and self-reported clinical skills of PRHOs: A pilot study (Medical Education (2003) 37 (597-602))
Probert, C. S., Cahill, D. J., McCann, G. L., & Ben-Shlomo, Y. (2003). Erratum: Traditional finals and OSCEs in predicting consultant and self-reported clinical skills of PRHOs: A pilot study (Medical Education (2003) 37 (597-602)). Medical Education, 37(11), 1058.
Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: control by a targeted vaccination programme and possible parenteral transmission
Syed, N. A., Hearing, S. D., Shaw, I. S., Probert, C. S. J., Brooklyn, T. N., Caul, E. O., . . . Sarangi, J. (2003). Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: control by a targeted vaccination programme and possible parenteral transmission. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 15(8), 901-906. doi:10.1097/00042737-200308000-00011
Parenteral nutrition via an arteriovenous bypass graft
Turner, S. M., Probert, C. S. J., & Lear, P. (2003). Parenteral nutrition via an arteriovenous bypass graft. GUT, 52(8), 1218. doi:10.1136/gut.52.8.1218
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis
Creed, T. J., Norman, M. R., Probert, C. S. J., Harvey, R. F., Shaw, I. S., Smithson, J., . . . Hearing, S. D. (2003). Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 18(1), 65-75. doi:10.1046/j.1365-2036.2003.01639.x
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis:: a randomised controlled trial
Probert, C. S. J., Hearing, S. D., Schreiber, S., Kühbacher, T., Ghosh, S., Arnott, I. D. R., & Forbes, A. (2003). Infliximab in moderately severe glucocorticoid resistant ulcerative colitis:: a randomised controlled trial. GUT, 52(7), 998-1002. doi:10.1136/gut.52.7.998
Traditional finals and OSCEs in predicting consultant and self-reported clinical skills of PRHOs: a pilot study
Probert, C. S., Cahill, D. J., McCann, G. L., & Ben-Shlomo, Y. (2003). Traditional finals and OSCEs in predicting consultant and self-reported clinical skills of PRHOs: a pilot study. MEDICAL EDUCATION, 37(7), 597-602. doi:10.1046/j.1365-2923.2003.01557.x
Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor
Terlevich, A., Hearing, S. D., Woltersdorf, W. W., Smyth, C., Reid, D., McCullagh, E., . . . Probert, C. S. J. (2003). Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 17(10), 1325-1329. doi:10.1046/j.1365-2036.2003.01567.x
Chemokine receptor CXCR3 expression by lamina propria T cells in Crohns disease
Brooklyn, T., Williams, A., & Probert, C. (2003). Chemokine receptor CXCR3 expression by lamina propria T cells in Crohns disease. Gastroenterology, 124(4), A337. doi:10.1016/s0016-5085(03)81698-0
Rising incidence of inflammatory bowel disease in Bangladeshis in East London
Tsironi, E., Feakins, R., Probert, C., & Rampton, D. (2003). Rising incidence of inflammatory bowel disease in Bangladeshis in East London. Gastroenterology, 124(4), A212. doi:10.1016/s0016-5085(03)81065-x
Diverticular Disease
Turner, S., & Probert, C. S. (2003). Diverticular Disease. Medicine, 31(3), 91-92. doi:10.1383/medc.31.3.91.28487
Evidence for the clinical use of infliximab in Crohn's disease.
Turner, S. M., & Probert, C. S. J. (2003). Evidence for the clinical use of infliximab in Crohn's disease.. Romanian journal of gastroenterology, 12(1), 2-5.
Teaching sexual history taking to medical students and examining it: experience in one medical school and a national survey
FitzGerald, M., Crowley, T., Greenhouse, P., Probert, C., & Horner, P. (2003). Teaching sexual history taking to medical students and examining it: experience in one medical school and a national survey. MEDICAL EDUCATION, 37(2), 94-98. doi:10.1046/j.1365-2923.2003.01411.x
A Crohn's repertoire:: T cell receptor γδ
Brooklyn, T., & Probert, C. (2003). A Crohn's repertoire:: T cell receptor γδ. INFLAMMATORY BOWEL DISEASES, 9(3), 213-214. Retrieved from https://www.webofscience.com/
2002
Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds
Shaw, I. S., Jobson, B. A., Silverman, D., Ford, J., Hearing, S. D., Ball, D., . . . Probert, C. S. J. (2002). Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 16(12), 2053-2059. doi:10.1046/j.1365-2036.2002.01375.x
ABC of Upper Gastrointestinal Disease.
ABC of Upper Gastrointestinal Disease. (2002). Postgraduate medical journal, 78(924), 635.
2001
Mucins in the gastrointestinal tract in health and disease
Corfield, A. P., Carroll, D., Myerscough, N., & Probert, C. S. J. (2001). Mucins in the gastrointestinal tract in health and disease. FRONTIERS IN BIOSCIENCE-LANDMARK, 6, D1321-D1357. doi:10.2741/Corfield
A man with a murmur requiring nutritional support.
Hearing, S. D., Shaw, I. S., Day, A., & Probert, C. S. (2001). A man with a murmur requiring nutritional support.. Postgraduate medical journal, 77(910), 535-545. doi:10.1136/pmj.77.910.535
A difficult case of gastrointestinal haemorrhage - Gastrointestinal haemorrhage due to oesphagogastric varices.
Shaw, I. S., Hearing, S. D., Callaway, M., & Probert, C. S. J. (2001). A difficult case of gastrointestinal haemorrhage - Gastrointestinal haemorrhage due to oesphagogastric varices.. POSTGRADUATE MEDICAL JOURNAL, 77(908), 408-+. doi:10.1136/pmj.77.908.408
An 80 year old woman with intermittent severe vomiting - Giant intrathoracic hiatus hernia.
Shaw, I. S., Hearing, S. D., & Probert, C. S. J. (2001). An 80 year old woman with intermittent severe vomiting - Giant intrathoracic hiatus hernia.. POSTGRADUATE MEDICAL JOURNAL, 77(907), 345-355. doi:10.1136/pmj.77.907.345
Prevalence of an ulcerative colitis-associated CD8<SUP>+</SUP> T cell receptor β-chain CDR3-region motif and its association with disease activity
Probert, C. S., Chott, A., Saubermann, L. J., Stevens, A. C., Balk, S. P., & Blumberg, R. S. (2001). Prevalence of an ulcerative colitis-associated CD8<SUP>+</SUP> T cell receptor β-chain CDR3-region motif and its association with disease activity. JOURNAL OF CLINICAL IMMUNOLOGY, 21(2), 126-134. doi:10.1023/A:1011007922707
An investigation of the association of the prothrombin G20210A gene mutation and inflammatory bowel disease: Factor II and IBD
Haslam, N., Standen, G. R., & Probert, C. S. (2001). An investigation of the association of the prothrombin G20210A gene mutation and inflammatory bowel disease: Factor II and IBD. INFLAMMATORY BOWEL DISEASES, 7(2), 133-135. doi:10.1097/00054725-200105000-00009
2000
Measles, month of birth, and Crohn's disease
Haslam, N., Mayberry, J. F., Hawthorne, A. B., Newcombe, R. G., Holmes, G. K. T., & Probert, C. S. J. (2000). Measles, month of birth, and Crohn's disease. GUT, 47(6), 801-803. doi:10.1136/gut.47.6.801
Factor V Leiden is not more frequent in inflammatory bowel disease
Papa, A., De Stefano, V., Gasbarrini, A., & Gasbarrini, G. (2000). Factor V Leiden is not more frequent in inflammatory bowel disease. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 12(7), 821-822. Retrieved from https://www.webofscience.com/
Mucins and inflammatory bowel disease
Shirazi, T., Longman, R. J., Corfield, A. P., & Probert, C. S. J. (2000). Mucins and inflammatory bowel disease. POSTGRADUATE MEDICAL JOURNAL, 76(898), 473-478. doi:10.1136/pmj.76.898.473
Audit of cyclosporin use in inflammatory bowel disease: limited benefits, numerous side-effects
Haslam, N., Hearing, S. D., & Probert, C. S. J. (2000). Audit of cyclosporin use in inflammatory bowel disease: limited benefits, numerous side-effects. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 12(6), 657-660. doi:10.1097/00042737-200012060-00015
1999
Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes
Hearing, S. D., Norman, M., Probert, C. S. J., Haslam, N., & Dayan, C. M. (1999). Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. GUT, 45(3), 382-388. doi:10.1136/gut.45.3.382
Evidence of T cell receptor β-chain patterns in inflammatory and noninflammatory bowel disease states
Saubermann, L. J., Probert, C. S. J., Christ, A. D., Chott, A., Turner, J. R., Stevens, A. C., . . . Blumberg, R. S. (1999). Evidence of T cell receptor β-chain patterns in inflammatory and noninflammatory bowel disease states. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 276(3), G613-G621. doi:10.1152/ajpgi.1999.276.3.G613
An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease
Haslam, N., Standen, G. R., & Probert, C. S. (1999). An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 11(11), 1289-1291. doi:10.1097/00042737-199911000-00018
1998
Sweet's syndrome without granulocytosis.
Probert, C., Ehmann, W. C., al-Mondhiry, H., Ballard, J., & Helm, K. F. (1998). Sweet's syndrome without granulocytosis.. International journal of dermatology, 37(2), 108-112. doi:10.1046/j.1365-4362.1998.00270.x
An audit of the investigation and treatment of folic acid deficiency
Haslam, N., & Probert, C. S. (1998). An audit of the investigation and treatment of folic acid deficiency. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 91(2), 72-73. doi:10.1177/014107689809100205
T-cell receptor usage in the intestine
Probert, C. S. J., Aitken, E. W., Saubermann, L. J., Balk, S. P., & Blumberg, R. S. (1998). T-cell receptor usage in the intestine. MUCOSAL T CELLS, 71, 27-39. Retrieved from https://www.webofscience.com/
1997
The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire
Moody, G. A., Probert, C., Jayanthi, V., & Mayberry, J. F. (1997). The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 12(4), 220-224. doi:10.1007/s003840050093
South Asians with ulcerative colitis exhibit altered lectin binding compared with matched European cases
McMahon, R. F. T., Warren, B. F., Jones, C. J. P., Mayberry, J. F., Probert, C. S. J., Corfield, A. P., & Stoddart, R. W. (1997). South Asians with ulcerative colitis exhibit altered lectin binding compared with matched European cases. HISTOCHEMICAL JOURNAL, 29(6), 469-477. doi:10.1023/A:1026407505561
Analysis of human common bile duct-associated T cells - Evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition
Probert, C. S., Christ, A. D., Saubermann, L. J., Turner, J. R., Chott, A., CarrLocke, D., . . . Blumberg, R. S. (1997). Analysis of human common bile duct-associated T cells - Evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition. JOURNAL OF IMMUNOLOGY, 158(4), 1941-1948. Retrieved from https://www.webofscience.com/
1996
Betel nut and smoking. Are they both protective in ulcerative colitis? A pilot study.
Lee, C. N., Jayanthi, V., McDonald, B., Probert, C. S., & Mayberry, J. F. (1996). Betel nut and smoking. Are they both protective in ulcerative colitis? A pilot study.. Arquivos de gastroenterologia, 33(1), 3-5.
Diet of South Asians with inflammatory bowel disease.
Probert, C. S., Bhakta, P., Bhamra, B., Jayanthi, V., & Mayberry, J. F. (1996). Diet of South Asians with inflammatory bowel disease.. Arquivos de gastroenterologia, 33(3), 132-135.
Quality of life after colectomy. A comparison of conventional ileostomy and sphincter saving continent procedures.
Probert, C. S., Jayanthi, V., & Mayberry, J. F. (1996). Quality of life after colectomy. A comparison of conventional ileostomy and sphincter saving continent procedures.. Arquivos de gastroenterologia, 33(2), 48-51.
Persistent clonal expansions of peripheral blood CD4(+) lymphocytes in chronic inflammatory bowel disease
Probert, C. S., Chott, A., Turner, J. R., Saubermann, L. J., Stevens, A. C., Bodinaku, K., . . . Blumberg, R. S. (1996). Persistent clonal expansions of peripheral blood CD4(+) lymphocytes in chronic inflammatory bowel disease. JOURNAL OF IMMUNOLOGY, 157(7), 3183-3191. Retrieved from https://www.webofscience.com/
A common TCR beta-chain expressed by CD8(+) intestinal mucosa T cells in ulcerative colitis
Chott, A., Probert, C. S., Gross, G. G., Blumberg, R. S., & Balk, S. P. (1996). A common TCR beta-chain expressed by CD8(+) intestinal mucosa T cells in ulcerative colitis. JOURNAL OF IMMUNOLOGY, 156(8), 3024-3035. Retrieved from https://www.webofscience.com/
Epidemiology of inflammatory bowel disease in different ethnic and religious groups: Limitations and aetiological clues
Probert, C. S. J., Jayanthi, V., Rampton, D. S., & Mayberry, J. F. (1996). Epidemiology of inflammatory bowel disease in different ethnic and religious groups: Limitations and aetiological clues. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 11(1), 25-28. doi:10.1007/BF00418851
Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: A retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire
Moody, G. A., Jayanthi, V., Probert, C. S. J., MacKay, H., & Mayberry, J. F. (1996). Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: A retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 8(12), 1179-1183. doi:10.1097/00042737-199612000-00009
Over-utilization of the J delta 3 gene-segment in Crohn's disease.
Landau, S. B., Probert, C. S., Stevens, C. A., Balk, S. P., & Blumberg, R. S. (1996). Over-utilization of the J delta 3 gene-segment in Crohn's disease.. Journal of clinical & laboratory immunology, 48(1), 33-44.
1995
Microcystin hepatitis.
Probert, C. S., Robinson, R. J., Jayanthi, V., & Mayberry, J. F. (1995). Microcystin hepatitis.. Arquivos de gastroenterologia, 32(4), 199.
COMPOSITION OF TCR-CD3 COMPLEX IN HUMAN INTESTINAL INTRAEPITHELIAL LYMPHOCYTES - LACK OF FC-EPSILON-RI-GAMMA CHAIN
BALK, S. P., POLISCHUK, J. E., PROBERT, C., STEVENS, C., EBERT, E., SHE, J., . . . BLUMBERG, R. S. (1995). COMPOSITION OF TCR-CD3 COMPLEX IN HUMAN INTESTINAL INTRAEPITHELIAL LYMPHOCYTES - LACK OF FC-EPSILON-RI-GAMMA CHAIN. INTERNATIONAL IMMUNOLOGY, 7(8), 1237-1241. doi:10.1093/intimm/7.8.1237
SOUTH ASIAN AND EUROPEAN COLITICS SHOW CHARACTERISTIC DIFFERENCES IN COLONIC MUCUS GLYCOPROTEIN TYPE AND TURNOVER
PROBERT, C. S. J., WARREN, B. F., PERRY, T., MACKAY, E. H., MAYBERRY, J. F., & CORFIELD, A. P. (1995). SOUTH ASIAN AND EUROPEAN COLITICS SHOW CHARACTERISTIC DIFFERENCES IN COLONIC MUCUS GLYCOPROTEIN TYPE AND TURNOVER. GUT, 36(5), 696-702. doi:10.1136/gut.36.5.696
SOME DETERMINANTS OF WHOLE-GUT TRANSIT-TIME - A POPULATION-BASED STUDY
PROBERT, C. S. J., EMMETT, P. M., & HEATON, K. W. (1995). SOME DETERMINANTS OF WHOLE-GUT TRANSIT-TIME - A POPULATION-BASED STUDY. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 88(5), 311-315. Retrieved from https://www.webofscience.com/
1994
EVIDENCE FOR THE AMBIGUITY OF THE TERM CONSTIPATION - THE ROLE OF IRRITABLE-BOWEL-SYNDROME
PROBERT, C. S. J., EMMETT, P. M., CRIPPS, H. A., & HEATON, K. W. (1994). EVIDENCE FOR THE AMBIGUITY OF THE TERM CONSTIPATION - THE ROLE OF IRRITABLE-BOWEL-SYNDROME. GUT, 35(10), 1455-1458. doi:10.1136/gut.35.10.1455
INFERTILITY, OBSTETRIC AND GYNECOLOGICAL PROBLEMS IN CELIAC SPRUE
SHER, K. S., JAYANTHI, V., PROBERT, C. S. J., STEWART, C. R., & MAYBERRY, J. F. (1994). INFERTILITY, OBSTETRIC AND GYNECOLOGICAL PROBLEMS IN CELIAC SPRUE. DIGESTIVE DISEASES, 12(3), 186-190. doi:10.1159/000171452
1993
PREVALENCE AND FAMILY RISK OF ULCERATIVE-COLITIS AND CROHNS-DISEASE - AN EPIDEMIOLOGIC-STUDY AMONG EUROPEANS AND SOUTH ASIANS IN LEICESTERSHIRE
PROBERT, C. S. J., JAYANTHI, V., HUGHES, A. O., THOMPSON, J. R., WICKS, A. C. B., & MAYBERRY, J. F. (1993). PREVALENCE AND FAMILY RISK OF ULCERATIVE-COLITIS AND CROHNS-DISEASE - AN EPIDEMIOLOGIC-STUDY AMONG EUROPEANS AND SOUTH ASIANS IN LEICESTERSHIRE. GUT, 34(11), 1547-1551. doi:10.1136/gut.34.11.1547
MORTALITY IN PATIENTS WITH ULCERATIVE-COLITIS IN LEICESTERSHIRE, 1972-1989 - AN EPIDEMIOLOGIC-STUDY
PROBERT, C. S. J., JAYANTHI, V., WICKS, A. C. B., & MAYBERRY, J. F. (1993). MORTALITY IN PATIENTS WITH ULCERATIVE-COLITIS IN LEICESTERSHIRE, 1972-1989 - AN EPIDEMIOLOGIC-STUDY. DIGESTIVE DISEASES AND SCIENCES, 38(3), 538-541. doi:10.1007/BF01316511
BRITISH GASTROENTEROLOGISTS CARE PROFILE FOR PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - THE NEED FOR A PATIENTS CHARTER
PROBERT, C. S. J., JAYANTHI, V., & MAYBERRY, J. F. (1993). BRITISH GASTROENTEROLOGISTS CARE PROFILE FOR PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - THE NEED FOR A PATIENTS CHARTER. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 86(5), 271-272. Retrieved from https://www.webofscience.com/
DISEASE VARIATIONS IN ASIANS IN LEICESTER
FEEHALLY, J., BURDEN, A. C., MAYBERRY, J. F., PROBERT, C. S. J., ROSHAN, M., SAMANTA, A. K., & WOODS, K. L. (1993). DISEASE VARIATIONS IN ASIANS IN LEICESTER. QUARTERLY JOURNAL OF MEDICINE, 86(4), 263-269. Retrieved from https://www.webofscience.com/
Errata
Errata (1993). Tubercle and Lung Disease, 74(3), 217. doi:10.1016/0962-8479(93)90018-s
HOW NECESSARY IS COLECTOMY - AN EPIDEMIOLOGIC-STUDY OF THE SURGICAL-MANAGEMENT OF ULCERATIVE-COLITIS AMONGST DIFFERENT ETHNIC-GROUPS IN LEICESTERSHIRE
PROBERT, C. S. J., JAYANTHI, V., BHAKTA, P., WICKS, T. C. B., & MAYBERRY, J. F. (1993). HOW NECESSARY IS COLECTOMY - AN EPIDEMIOLOGIC-STUDY OF THE SURGICAL-MANAGEMENT OF ULCERATIVE-COLITIS AMONGST DIFFERENT ETHNIC-GROUPS IN LEICESTERSHIRE. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 5(1), 17-20. Retrieved from https://www.webofscience.com/
INCIDENCE OF ABDOMINAL TUBERCULOSIS IN BANGLADESHI MIGRANTS IN EAST LONDON
SHELDON, C. D., PROBERT, C. S. J., COCK, H., KING, K., RAMPTON, D. S., BARNES, N. C., & MAYBERRY, J. F. (1993). INCIDENCE OF ABDOMINAL TUBERCULOSIS IN BANGLADESHI MIGRANTS IN EAST LONDON. TUBERCLE AND LUNG DISEASE, 74(1), 12-15. doi:10.1016/0962-8479(93)90061-2
Malignant Hypertension due to Embolisation of a Clear Cell Renal Carcinoma
PROBERT, C. S. J., OSBORN, D. E., & WATKIN, E. M. (1993). Malignant Hypertension due to Embolisation of a Clear Cell Renal Carcinoma. British Journal of Urology, 72(2), 95-96. doi:10.1111/j.1464-410x.1992.tb16154.x
PATIENTS SATISFACTION SURVEY - A REVIEW OF INPATIENT ATTITUDES TOWARDS CARE DURING A 12-MONTH PERIOD
GAY, S., BRADSHAW, K., OBOURKE, T., CHUAH, Y., PROBERT, C., & MAYBERRY, J. (1993). PATIENTS SATISFACTION SURVEY - A REVIEW OF INPATIENT ATTITUDES TOWARDS CARE DURING A 12-MONTH PERIOD. JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 113(3), 121-123. doi:10.1177/146642409311300305
PROCTITIS AND PROCTOSIGMOIDITIS - A NEED TO IDENTIFY THE EXTENT OF DISEASE IN EPIDEMIOLOGIC SURVEYS
JAYANTHI, V., CHUAH, S. Y., PROBERT, C. S. J., MAYBERRY, M., & MAYBERRY, J. F. (1993). PROCTITIS AND PROCTOSIGMOIDITIS - A NEED TO IDENTIFY THE EXTENT OF DISEASE IN EPIDEMIOLOGIC SURVEYS. DIGESTION, 54(1), 61-64. doi:10.1159/000201013
THE RENAISSANCE OF ABDOMINAL TUBERCULOSIS
JAYANTHI, V., PROBERT, C. S. J., SHER, K. S., WICKS, A. C. B., & MAYBERRY, J. F. (1993). THE RENAISSANCE OF ABDOMINAL TUBERCULOSIS. DIGESTIVE DISEASES, 11(1), 36-44. doi:10.1159/000171399
1992
CROHNS-DISEASE IN BANGLADESHIS AND EUROPEANS IN BRITAIN - AN EPIDEMIOLOGIC COMPARISON IN TOWER HAMLETS
PROBERT, C. S. J., JAYANTHI, V., POLLOCK, D. J., BAITHUN, S. I., MAYBERRY, J. F., & RAMPTON, D. S. (1992). CROHNS-DISEASE IN BANGLADESHIS AND EUROPEANS IN BRITAIN - AN EPIDEMIOLOGIC COMPARISON IN TOWER HAMLETS. POSTGRADUATE MEDICAL JOURNAL, 68(805), 914-920. doi:10.1136/pgmj.68.805.914
MORTALITY FROM CROHNS-DISEASE IN LEICESTERSHIRE, 1972-1989 - AN EPIDEMIOLOGIC COMMUNITY BASED STUDY
PROBERT, C. S. J., JAYANTHI, V., WICKS, A. C. B., & MAYBERRY, J. F. (1992). MORTALITY FROM CROHNS-DISEASE IN LEICESTERSHIRE, 1972-1989 - AN EPIDEMIOLOGIC COMMUNITY BASED STUDY. GUT, 33(9), 1226-1228. doi:10.1136/gut.33.9.1226
EPIDEMIOLOGIC-STUDY OF ABDOMINAL TUBERCULOSIS AMONG INDIAN MIGRANTS AND THE INDIGENOUS POPULATION OF LEICESTER, 1972-1989
PROBERT, C. S. J., JAYANTHI, V., WICKS, A. C., CARRLOCKE, D. L., GARNER, P., & MAYBERRY, J. F. (1992). EPIDEMIOLOGIC-STUDY OF ABDOMINAL TUBERCULOSIS AMONG INDIAN MIGRANTS AND THE INDIGENOUS POPULATION OF LEICESTER, 1972-1989. GUT, 33(8), 1085-1088. doi:10.1136/gut.33.8.1085
EPIDEMIOLOGIC-STUDY OF ULCERATIVE PROCTOCOLITIS IN INDIAN MIGRANTS AND THE INDIGENOUS POPULATION OF LEICESTERSHIRE
PROBERT, C. S. J., JAYANTHI, V., PINDER, D., WICKS, A. C., & MAYBERRY, J. F. (1992). EPIDEMIOLOGIC-STUDY OF ULCERATIVE PROCTOCOLITIS IN INDIAN MIGRANTS AND THE INDIGENOUS POPULATION OF LEICESTERSHIRE. GUT, 33(5), 687-693. doi:10.1136/gut.33.5.687
Management of coeliac disease: a changing diagnostic approach but what value in follow up?
Acalovschi, M., Jayanthi, V., Probert, C. S., & Mayberry, J. F. (1992). Management of coeliac disease: a changing diagnostic approach but what value in follow up?. Quality in health care : QHC, 1(1), 26-28. doi:10.1136/qshc.1.1.26
PERCEIVED DISCRIMINATION IN EDUCATION AND EMPLOYMENT BY PEOPLE WITH CROHNS-DISEASE - A CASE CONTROL STUDY OF EDUCATIONAL-ACHIEVEMENT AND EMPLOYMENT
MAYBERRY, M. K., PROBERT, C., SRIVASTAVA, E., RHODES, J., & MAYBERRY, J. F. (1992). PERCEIVED DISCRIMINATION IN EDUCATION AND EMPLOYMENT BY PEOPLE WITH CROHNS-DISEASE - A CASE CONTROL STUDY OF EDUCATIONAL-ACHIEVEMENT AND EMPLOYMENT. GUT, 33(3), 312-314. doi:10.1136/gut.33.3.312
STOMA ANXIETIES - A COMPARISON OF THE ATTITUDES OF ASIAN MIGRANTS AND THE INDIGENOUS POPULATION IN THE UNITED-KINGDOM TOWARDS ABDOMINAL-SURGERY AND THE ROLE OF INTESTINAL STOMAS
BHAKTA, P., PROBERT, C. S. J., JAYANTHI, V., & MAYBERRY, J. F. (1992). STOMA ANXIETIES - A COMPARISON OF THE ATTITUDES OF ASIAN MIGRANTS AND THE INDIGENOUS POPULATION IN THE UNITED-KINGDOM TOWARDS ABDOMINAL-SURGERY AND THE ROLE OF INTESTINAL STOMAS. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 7(1), 1-3. doi:10.1007/BF01647650
DIETARY FATS AND INFLAMMATORY BOWEL-DISEASE IN ASIANS
CHUAH, S. Y., JAYANTHI, V., LEE, C. N., MCDONALD, B., PROBERT, C. S. J., & MAYBERRY, J. F. (1992). DIETARY FATS AND INFLAMMATORY BOWEL-DISEASE IN ASIANS. ITALIAN JOURNAL OF GASTROENTEROLOGY, 24(7), 386-388. Retrieved from https://www.webofscience.com/
EDUCATION AND YOUNG-PEOPLE WITH INFLAMMATORY BOWEL-DISEASE
PROBERT, C. S. J., MAYBERRY, M., & MAYBERRY, J. F. (1992). EDUCATION AND YOUNG-PEOPLE WITH INFLAMMATORY BOWEL-DISEASE. JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 112(3), 112-113. doi:10.1177/146642409211200301
EPIDEMIOLOGY OF CROHNS-DISEASE IN INDIAN MIGRANTS AND THE INDIGENOUS POPULATION IN LEICESTERSHIRE
JAYANTHI, V., PROBERT, C. S. J., PINDER, D., WICKS, A. C. B., & MAYBERRY, J. F. (1992). EPIDEMIOLOGY OF CROHNS-DISEASE IN INDIAN MIGRANTS AND THE INDIGENOUS POPULATION IN LEICESTERSHIRE. QUARTERLY JOURNAL OF MEDICINE, 82(298), 125-138. Retrieved from https://www.webofscience.com/
GRANULOMAS IN INFLAMMATORY BOWEL-DISEASE - ARE THEY OF DIAGNOSTIC OR ETIOLOGIC SIGNIFICANCE
JAYANTHI, V., PROBERT, C. S., MACKAY, E. H., WILLIAMS, G. T., & MAYBERRY, J. F. (1992). GRANULOMAS IN INFLAMMATORY BOWEL-DISEASE - ARE THEY OF DIAGNOSTIC OR ETIOLOGIC SIGNIFICANCE. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 4(1), 15-17. Retrieved from https://www.webofscience.com/
LOW INCIDENCE OF ULCERATIVE-COLITIS AND PROCTITIS IN BANGLADESHI MIGRANTS IN BRITAIN
JAYANTHI, V., PROBERT, C. S. J., POLLOCK, D. J., BAITHUN, S. I., RAMPTON, D. S., & MAYBERRY, J. F. (1992). LOW INCIDENCE OF ULCERATIVE-COLITIS AND PROCTITIS IN BANGLADESHI MIGRANTS IN BRITAIN. DIGESTION, 52(1), 34-42. doi:10.1159/000200936
MALIGNANT HYPERTENSION DUE TO EMBOLIZATION OF A CLEAR CELL RENAL-CARCINOMA
PROBERT, C. S. J., OSBORN, D. E., & WATKIN, E. M. (1992). MALIGNANT HYPERTENSION DUE TO EMBOLIZATION OF A CLEAR CELL RENAL-CARCINOMA. BRITISH JOURNAL OF UROLOGY, 70(1), 95-96. doi:10.1111/j.1464-410X.1992.tb15674.x
MERCURY BOUGIE SELF-DILATION OF THE ESOPHAGUS IN THE 1990S
MOODY, G. A., MAYBERRY, J. F., & PROBERT, C. S. J. (1992). MERCURY BOUGIE SELF-DILATION OF THE ESOPHAGUS IN THE 1990S. JOURNAL OF CLINICAL GASTROENTEROLOGY, 15(3), 264. doi:10.1097/00004836-199210000-00020
ORAL SUBMUCOSAL FIBROSIS - A PREVENTABLE DISEASE
JAYANTHI, V., PROBERT, C. S. J., SHER, K. S., & MAYBERRY, J. F. (1992). ORAL SUBMUCOSAL FIBROSIS - A PREVENTABLE DISEASE. GUT, 33(1), 4-6. doi:10.1136/gut.33.1.4
SEXUAL DYSFUNCTION AMONGST WOMEN WITH CROHNS-DISEASE - A HIDDEN PROBLEM
MOODY, G., PROBERT, C. S. J., SRIVASTAVA, E. M., RHODES, J., & MAYBERRY, J. F. (1992). SEXUAL DYSFUNCTION AMONGST WOMEN WITH CROHNS-DISEASE - A HIDDEN PROBLEM. DIGESTION, 52(3-4), 179-183. doi:10.1159/000200951
THE ATTITUDE OF EMPLOYERS TO PEOPLE WITH INFLAMMATORY BOWEL-DISEASE
MOODY, G. A., PROBERT, C. S. J., JAYANTHI, V., & MAYBERRY, J. F. (1992). THE ATTITUDE OF EMPLOYERS TO PEOPLE WITH INFLAMMATORY BOWEL-DISEASE. SOCIAL SCIENCE & MEDICINE, 34(4), 459-460. doi:10.1016/0277-9536(92)90306-B
1991
Achalasia and diet: assessment of the effect of achalasia on the diet of patients and their spouses.
Probert, C. S., Spiller, R., Atkinson, M., & Mayberry, J. F. (1991). Achalasia and diet: assessment of the effect of achalasia on the diet of patients and their spouses.. Dysphagia, 6(3), 145-146. doi:10.1007/bf02493517
DRAMATIC OLIGOCLONAL PARAPROTEINEMIA FOLLOWING A PNEUMOCOCCAL SEPTICEMIA
PROBERT, C. S. J., ROLAND, J. M., SIMPSON, K. R., & FAIRHAM, S. A. (1991). DRAMATIC OLIGOCLONAL PARAPROTEINEMIA FOLLOWING A PNEUMOCOCCAL SEPTICEMIA. POSTGRADUATE MEDICAL JOURNAL, 67(785), 295-296. doi:10.1136/pgmj.67.785.295
A Study of the Menopause in Women with Ulcerative Colitis
Lichtarowicz, A., Srivastava, E., Norman, C., Rhodes, J., Tregaskis, B., Jayanthi, V., . . . Mayberry, J. F. (1991). A Study of the Menopause in Women with Ulcerative Colitis. Journal of Obstetrics and Gynaecology, 11(5), 361-364. doi:10.3109/01443619109007786
ARE WE WASTING TIME IN OUT-PATIENTS DEPARTMENTS
MATTHEWS, F. J. F., PROBERT, C. S. J., BATTCOCK, T., FRISBY, S. D., CHANDAR, M., & MAYBERRY, J. F. (1991). ARE WE WASTING TIME IN OUT-PATIENTS DEPARTMENTS. PUBLIC HEALTH, 105(3), 239-242. doi:10.1016/S0033-3506(05)80113-1
Barrett's oesophagus--a review.
Probert, C. S., Jayanthi, V., & Mayberry, J. F. (1991). Barrett's oesophagus--a review.. The Quarterly journal of medicine, 81(295), 883-889.
CURRENT CONCEPTS OF THE ETIOPATHOGENESIS OF INFLAMMATORY BOWEL-DISEASE
JAYANTHI, V., PROBERT, C. S. J., SHER, K. S., & MAYBERRY, J. F. (1991). CURRENT CONCEPTS OF THE ETIOPATHOGENESIS OF INFLAMMATORY BOWEL-DISEASE. AMERICAN JOURNAL OF GASTROENTEROLOGY, 86(11), 1566-1572. Retrieved from https://www.webofscience.com/
DIFFERENTIAL-DIAGNOSIS OF INFLAMMATORY BOWEL-DISEASE - A COMPARISON OF VARIOUS DIAGNOSTIC CLASSIFICATIONS
SHIVANANDA, S., HORDIJK, M. L., TENKATE, F. J. W., PROBERT, C. S. J., & MAYBERRY, J. F. (1991). DIFFERENTIAL-DIAGNOSIS OF INFLAMMATORY BOWEL-DISEASE - A COMPARISON OF VARIOUS DIAGNOSTIC CLASSIFICATIONS. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 26(2), 167-173. doi:10.3109/00365529109025027
EPIDEMIOLOGY OF INFLAMMATORY BOWEL-DISEASE
JAYANTHI, V., PROBERT, C. S. J., & MAYBERRY, J. F. (1991). EPIDEMIOLOGY OF INFLAMMATORY BOWEL-DISEASE. QUARTERLY JOURNAL OF MEDICINE, 78(285), 5-12. Retrieved from https://www.webofscience.com/
INFLAMMATORY BOWEL-DISEASE - PATIENTS EXPECTATIONS IN THE 1990S
PROBERT, C. S. J., & MAYBERRY, J. F. (1991). INFLAMMATORY BOWEL-DISEASE - PATIENTS EXPECTATIONS IN THE 1990S. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 84(3), 131-132. doi:10.1177/014107689108400305
INFLAMMATORY BOWEL-DISEASE IN INDIAN MIGRANTS IN FIJI
PROBERT, C. S. J., JAYANTHI, V., & MAYBERRY, J. F. (1991). INFLAMMATORY BOWEL-DISEASE IN INDIAN MIGRANTS IN FIJI. DIGESTION, 50(2), 82-84. doi:10.1159/000200743
INFORMATION REQUIREMENTS AND SEDATION PREFERENCES OF PATIENTS UNDERGOING ENDOSCOPY OF THE UPPER GASTROINTESTINAL-TRACT
PROBERT, C. S. J., JAYANTHI, V., QUINN, J., & MAYBERRY, J. F. (1991). INFORMATION REQUIREMENTS AND SEDATION PREFERENCES OF PATIENTS UNDERGOING ENDOSCOPY OF THE UPPER GASTROINTESTINAL-TRACT. ENDOSCOPY, 23(4), 218-219. doi:10.1055/s-2007-1010661
Many people seek the opinion of a doctor when ill.
McDonald, B., Lee, C. N., Jayanthi, V., Probert, C. S., & Mayberry, J. F. (1991). Many people seek the opinion of a doctor when ill.. Social science & medicine (1982), 33(9), 1091. doi:10.1016/0277-9536(91)90014-4
PATIENTS ASSESSMENT OF AN INFORMATION BOOKLET ON CROHNS-DISEASE WRITTEN BY A PATIENT
PROBERT, C. S. J., GODBER, D., CALCRAFT, B., & MAYBERRY, J. F. (1991). PATIENTS ASSESSMENT OF AN INFORMATION BOOKLET ON CROHNS-DISEASE WRITTEN BY A PATIENT. ITALIAN JOURNAL OF GASTROENTEROLOGY, 23(5), 239-243. Retrieved from https://www.webofscience.com/
PATIENTS VIEWS ON HOW TO RUN HOSPITAL OUTPATIENT CLINICS
BISHOP, F., MATTHEWS, F. J., PROBERT, C. S. J., BILLETT, J., BATTCOCK, T., FRISBY, S. D., & MAYBERRY, J. F. (1991). PATIENTS VIEWS ON HOW TO RUN HOSPITAL OUTPATIENT CLINICS. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 84(9), 522-523. doi:10.1177/014107689108400906
PROBLEMS FOR A PATIENT UNDER THE COURT OF PROTECTION
BATTCOCK, T., BATTCOCK, B., KIRBY, R., WILLIAMS, R., MATTHEWS, F., PROBERT, C., & MAYBERRY, J. (1991). PROBLEMS FOR A PATIENT UNDER THE COURT OF PROTECTION. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 84(6), 331. doi:10.1177/014107689108400603
SMOKING AND PREVENTION
JAYANTHI, V., PROBERT, C. S. J., SHER, K. S., & MAYBERRY, J. F. (1991). SMOKING AND PREVENTION. RESPIRATORY MEDICINE, 85(3), 179-183. doi:10.1016/S0954-6111(06)80076-4
SOME EPIDEMIOLOGIC AND ETIOLOGIC ASPECTS OF ACHALASIA
MAYBERRY, J. F., PROBERT, C. S. J., SHER, K. S., & ATKINSON, M. (1991). SOME EPIDEMIOLOGIC AND ETIOLOGIC ASPECTS OF ACHALASIA. DIGESTIVE DISEASES, 9(1), 1-8. doi:10.1159/000171288
THE ROLE OF EDUCATIONAL VIDEOS IN GASTROENTEROLOGY
PROBERT, C. S. J., FRISBY, S., & MAYBERRY, J. F. (1991). THE ROLE OF EDUCATIONAL VIDEOS IN GASTROENTEROLOGY. JOURNAL OF CLINICAL GASTROENTEROLOGY, 13(6), 620-621. Retrieved from https://www.webofscience.com/
1990
DIET, DIABETES, AND MALE-CHAUVINISM
PROBERT, C. S. J., MADDISON, W., & ROLAND, J. M. (1990). DIET, DIABETES, AND MALE-CHAUVINISM. BRITISH MEDICAL JOURNAL, 301(6766), 1430-1431. doi:10.1136/bmj.301.6766.1430
INFLAMMATORY BOWEL-DISEASE AMONGST WELSH MIGRANTS AND THEIR DESCENDANTS IN THE UNITED-STATES OF AMERICA
PROBERT, C. S. J., ROBERTS, A. L., SHIVANANDA, S., & MAYBERRY, J. F. (1990). INFLAMMATORY BOWEL-DISEASE AMONGST WELSH MIGRANTS AND THEIR DESCENDANTS IN THE UNITED-STATES OF AMERICA. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2(6), 463-465. Retrieved from https://www.webofscience.com/
CONSUMER, CUSTOMER, CLIENT, OR PATIENT
PROBERT, C. S. J., BATTCOCK, T., & MAYBERRY, J. F. (1990). CONSUMER, CUSTOMER, CLIENT, OR PATIENT. LANCET, 335(8703), 1466-1467. doi:10.1016/0140-6736(90)91498-Y
INFLAMMATORY BOWEL-DISEASE AND THE NURSE COUNSELOR
PROBERT, C. S. J., LONG, R., & MAYBERRY, J. F. (1990). INFLAMMATORY BOWEL-DISEASE AND THE NURSE COUNSELOR. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2(4), 317-318. Retrieved from https://www.webofscience.com/
INFLAMMATORY BOWEL-DISEASE IN THE RURAL INDIAN SUBCONTINENT - A SURVEY OF PATIENTS ATTENDING MISSION HOSPITALS
PROBERT, C. S. J., MAYBERRY, J. F., & MANN, R. (1990). INFLAMMATORY BOWEL-DISEASE IN THE RURAL INDIAN SUBCONTINENT - A SURVEY OF PATIENTS ATTENDING MISSION HOSPITALS. DIGESTION, 47(1), 42-46. doi:10.1159/000200475
STEROID RESPONSIVE CARDIOMYOPATHY
PROBERT, C. S. J., PAVORD, I., & ROLAND, J. (1990). STEROID RESPONSIVE CARDIOMYOPATHY. INTERNATIONAL JOURNAL OF CARDIOLOGY, 28(2), 257-258. doi:10.1016/0167-5273(90)90069-H
1989
BERIBERI SECONDARY TO TOOTH-DECAY
PROBERT, C. S. J. (1989). BERIBERI SECONDARY TO TOOTH-DECAY. LANCET, 2(8653), 51-52. Retrieved from https://www.webofscience.com/